129722-12-9 | 7-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinol in-2-one

Packsize	Purity	Availability	Price	Discounted Price
1g	99%(HPLC)	in stock	$24.00	$17.00
5g	98%	in stock	$50.00	$35.00
25g	98%	in stock	$155.00	$108.00
100g	98%	in stock	$473.00	$331.00

Description

• Catalog Number: AA38191
• Chemical Name: 7-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinol in-2-one
• CAS Number: 129722-12-9
• Molecular Formula: C23H27Cl2N3O2
• Molecular Weight: 448.3854
• MDL Number: MFCD00892072
• SMILES: O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl
• NSC Number: 759266

Computed Properties

• Complexity: 559
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 30
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 7
• XLogP3: 4.6

Literature

• Why are most phospholipidosis inducers also hERG blockers?

  Archives of toxicology 20171201

• Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia.

  American health & drug benefits 20160301

• Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents.

  Clinical schizophrenia & related psychoses 20160101

• Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug.

  Results in pharma sciences 20140101

• Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.

  European journal of medicinal chemistry 20130201

• Modeling alcohol self-administration in the human laboratory.

  Current topics in behavioral neurosciences 20130101

• Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity.

  Neuropharmacology 20130101

• Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20121203

• Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.

  International journal of pharmaceutics 20121115

• Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.

  Biomedical chromatography : BMC 20121101

• Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells.

  Journal of neural transmission (Vienna, Austria : 1996) 20121101

• Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.

  Journal of the American Academy of Child and Adolescent Psychiatry 20121101

• A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia.

  European psychiatry : the journal of the Association of European Psychiatrists 20121001

• New treatment guidelines for acute bipolar mania: a critical review.

  Journal of affective disorders 20121001

• Association analysis of ZNF804A (zinc finger protein 804A) rs1344706 with therapeutic response to atypical antipsychotics in first-episode Chinese patients with schizophrenia.

  Comprehensive psychiatry 20121001

• Preliminary studies of (99m)Tc-memantine derivatives for NMDA receptor imaging.

  Nuclear medicine and biology 20121001

• Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder.

  Psychopharmacology 20121001

• Is there a role for loading dose regimes in aripiprazole therapy?

  The Australian and New Zealand journal of psychiatry 20121001

• A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania.

  International journal of psychiatry in clinical practice 20121001

• Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia.

  Journal of clinical psychopharmacology 20121001

• Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial).

  Depression and anxiety 20121001

• Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole.

  Journal of clinical pharmacy and therapeutics 20121001

• Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.

  Expert opinion on pharmacotherapy 20121001

• New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?

  Clinical schizophrenia & related psychoses 20121001

• Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole.

  Translational psychiatry 20121001

• Aggression and self-injury in a patient with severe autism.

  Pediatric annals 20121001

• Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.

  Psychiatry and clinical neurosciences 20121001

• Aripiprazole, alcohol and substance abuse: a review.

  European review for medical and pharmacological sciences 20121001

• Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.

  Schizophrenia bulletin 20120901

• Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient.

  Journal of clinical pharmacology 20120901

• Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.

  Journal of psychopharmacology (Oxford, England) 20120901

• Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder.

  Nordic journal of psychiatry 20120901

• Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.

  Journal of psychopharmacology (Oxford, England) 20120901

• Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.

  Biopharmaceutics & drug disposition 20120901

• Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.

  Expert opinion on drug safety 20120901

• Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.

  Human psychopharmacology 20120901

• [Dysphagia or dysphagias during neuroleptic medication?].

  L'Encephale 20120901

• Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists.

  Journal of medicinal chemistry 20120823

• A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia.

  Expert opinion on pharmacotherapy 20120801

• Hyperprolactinaemia on depot risperidone treated with aripiprazole.

  The Australian and New Zealand journal of psychiatry 20120801

• Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

  Current psychiatry reports 20120801

• Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients.

  Journal of clinical psychopharmacology 20120801

• The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

  Journal of child and adolescent psychopharmacology 20120801

• A comparison of the effects of the dopamine partial agonists aripiprazole and (-)-3-PPP with quinpirole on stimulated dopamine release in the rat striatum: Studies using fast cyclic voltammetry in vitro.

  European journal of pharmacology 20120705

• Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.

  Schizophrenia bulletin 20120701

• Increased Cdk5/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats.

  The international journal of neuropsychopharmacology 20120701

• Olanzapine and benztropine as a cause of ischemic colitis in a 27-year-old man.

  Journal of clinical gastroenterology 20120701

• Treatment practices in Tourette syndrome: the European perspective.

  European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20120701

• Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.

  Psychopharmacology 20120701

• Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.

  International clinical psychopharmacology 20120701

• Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats.

  Pharmaceutical research 20120701

• Efficacy and safety of aripiprazole in child and adolescent patients.

  European child & adolescent psychiatry 20120701

• An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.

  International clinical psychopharmacology 20120701

• Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.

  Acta psychiatrica Scandinavica 20120701

• Safety and tolerability of antipsychotic polypharmacy.

  Expert opinion on drug safety 20120701

• Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months.

  Human psychopharmacology 20120701

• [Therapy of tic disorders].

  Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20120701

• Systemic review of aripiprazole for the treatment of children and adolescents with tic disorders.

  Neurosciences (Riyadh, Saudi Arabia) 20120701

• INN common stem: -piprazole.

  Prescrire international 20120701

• [Fewer side effects and lower mortality from modern antipsychotic drugs. But they are more expensive than older antipsychotics, based on a study from Västra Götaland].

  Lakartidningen 20120701

• Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.

  Postgraduate medicine 20120701

• [Pharmacotherapy for conduct disorder in children and adolescents].

  Harefuah 20120701

• Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.

  Journal of medicinal chemistry 20120614

• Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.

  Journal of psychopharmacology (Oxford, England) 20120601

• Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release.

  The international journal of neuropsychopharmacology 20120601

• Tolerability profile of aripiprazole in patients with Tourette syndrome.

  Journal of psychopharmacology (Oxford, England) 20120601

• Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.

  Journal of clinical pharmacy and therapeutics 20120601

• Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.

  International journal of psychiatry in clinical practice 20120601

• Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.

  International journal of psychiatry in clinical practice 20120601

• Is rational antipsychotic polytherapy feasible? A selective review.

  Current psychiatry reports 20120601

• The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.

  Journal of psychiatric research 20120601

• Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.

  AAPS PharmSciTech 20120601

• A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism.

  Journal of child and adolescent psychopharmacology 20120601

• Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.

  Journal of clinical psychopharmacology 20120601

• Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice.

  Behavioural pharmacology 20120601

• Oral aripiprazole-induced severe hypoglycemia.

  Therapeutic drug monitoring 20120601

• Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

  European archives of psychiatry and clinical neuroscience 20120601

• Chemical structure does not define obviousness.

  Nature reviews. Drug discovery 20120601

• Aripiprazole salts. II. Aripiprazole perchlorate.

  Acta crystallographica. Section C, Crystal structure communications 20120601

• Rash in psychiatric and nonpsychiatric adolescent patients receiving lamotrigine in Korea: a retrospective cohort study.

  Psychiatry investigation 20120601

• Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

  Journal of managed care pharmacy : JMCP 20120601

• Aripiprazole for autism spectrum disorders (ASD).

  The Cochrane database of systematic reviews 20120516

• Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.

  Physiology & behavior 20120515

• Risk factors for ileus in patients with schizophrenia.

  Schizophrenia bulletin 20120501

• Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.

  Journal of psychopharmacology (Oxford, England) 20120501

• Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120501

• Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: findings from a grounded theory study.

  Journal of psychiatric and mental health nursing 20120501

• Aripiprazole vs placebo for schizophrenia.

  Schizophrenia bulletin 20120501

• Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.

  International clinical psychopharmacology 20120501

• New directions in the treatment of autism spectrum disorders from animal model research.

  Expert opinion on drug discovery 20120501

• Maintenance therapies in bipolar disorders.

  Bipolar disorders 20120501

• Review of the pharmacotherapy of irritability of autism.

  Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20120501

• Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.

  The Annals of pharmacotherapy 20120501

• Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.

  The Journal of clinical psychiatry 20120501

• Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120501

• Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone.

  Progress in neuro-psychopharmacology & biological psychiatry 20120427

• The complexity of hydration of phloroglucinol: a comprehensive structural and thermodynamic characterization.

  The journal of physical chemistry. B 20120405

• Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20120401

• The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.

  The Journal of clinical psychiatry 20120401

• The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium.

  Journal of clinical psychopharmacology 20120401

• Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.

  Journal of child and adolescent psychopharmacology 20120401

• Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.

  Therapeutic drug monitoring 20120401

• Tardive laryngeal dystonia associated with aripiprazole monotherapy.

  Journal of clinical psychopharmacology 20120401

• Determination of a highly selective mixed-affinity sigma receptor ligand, in rat plasma by ultra performance liquid chromatography mass spectrometry and its application to a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120401

• Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.

  Psychiatry and clinical neurosciences 20120401

• Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.

  Clinical therapeutics 20120401

• Aripiprazole salts. I. Aripiprazole nitrate.

  Acta crystallographica. Section C, Crystal structure communications 20120401

• Efficacy of aripiprazole in comorbid addiction in bipolar disorder.

  CNS neuroscience & therapeutics 20120401

• [Methodological approach to inter 'guideline' variability in the management of bipolar disorders].

  L'Encephale 20120401

• Hiccup: mystery, nature and treatment.

  Journal of neurogastroenterology and motility 20120401

• An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite.

  Journal of pharmaceutical and biomedical analysis 20120325

• High dosage of aripiprazole-induced dysphagia.

  The International journal of eating disorders 20120301

• Methamphetamine-associated psychosis.

  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20120301

• Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).

  European archives of psychiatry and clinical neuroscience 20120301

• Aripiprazole induced transient myopia: a case report and review of literature.

  Cutaneous and ocular toxicology 20120301

• Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.

  The international journal of neuropsychopharmacology 20120301

• Clozapine resistance: augmentation strategies.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120301

• Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats.

  Psychopharmacology 20120301

• Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.

  The Journal of clinical psychiatry 20120301

• Effect of vehicle systems, pH and enhancers on the permeation of highly lipophilic aripiprazole from Carbopol 971P gel systems across human cadaver skin.

  Drug development and industrial pharmacy 20120301

• State of the art: treatment of bipolar disorders.

  CNS neuroscience & therapeutics 20120301

• Refractoriness in bipolar disorder: definitions and evidence-based treatment.

  CNS neuroscience & therapeutics 20120301

• Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.

  Drug metabolism and disposition: the biological fate of chemicals 20120301

• Atypical antipsychotic-induced mania/hypomania: a review of recent case reports and clinical studies.

  International journal of psychiatry in clinical practice 20120301

• [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].

  Psychiatrische Praxis 20120301

• No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.

  International clinical psychopharmacology 20120301

• Neurobiology of schizophrenia: from outcome to pathophysiological insights.

  European archives of psychiatry and clinical neuroscience 20120301

• Loxapine P-glycoprotein interactions in vitro.

  Drug metabolism letters 20120301

• Aripiprazole may be free from tachyphylaxis: preliminary findings.

  Psychiatry and clinical neurosciences 20120301

• Interactions between antiepileptics and second-generation antipsychotics.

  Expert opinion on drug metabolism & toxicology 20120301

• Emerging drugs for major depressive disorder.

  Expert opinion on emerging drugs 20120301

• Emergence of psychotic symptoms during Internet withdrawal.

  Psychiatry and clinical neurosciences 20120301

• Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20120301

• Does aripiprazole protect from serotonin syndrome?

  Psychiatria Danubina 20120301

• Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.

  PLoS medicine 20120301

• [Medication review for dementia patients].

  Medizinische Monatsschrift fur Pharmazeuten 20120301

• Drug-induced parkinsonism.

  Journal of clinical neurology (Seoul, Korea) 20120301

• Trends in combination antipsychotic use among persons with commercial insurance: a data snapshot.

  Innovations in clinical neuroscience 20120301

• Modeling of bias for the analysis of receptor signaling in biochemical systems.

  Biochemistry 20120214

• Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat.

  Psychopharmacology 20120201

• Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120201

• Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.

  Neuropharmacology 20120201

• Comparison of academic and nonacademic sites in multi-center clinical trials.

  Journal of clinical psychopharmacology 20120201

• The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.

  Journal of clinical psychopharmacology 20120201

• Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.

  Journal of clinical psychopharmacology 20120201

• A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder.

  Journal of affective disorders 20120201

• Intermittent aripiprazole for schizophrenia.

  Schizophrenia research 20120201

• Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

  Journal of the American Academy of Child and Adolescent Psychiatry 20120201

• The role of antipsychotics in the management of fibromyalgia.

  CNS drugs 20120201

• Aripiprazole: a review of its use in the management of schizophrenia in adults.

  CNS drugs 20120201

• Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).

  Bipolar disorders 20120201

• Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.

  Gender medicine 20120201

• The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.

  The western journal of emergency medicine 20120201

• [Pharmacology of antipsychotics at human dopamine D2 and D3 receptors].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20120201

• Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20120110

• Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.

  Schizophrenia bulletin 20120101

• Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder.

  CNS neuroscience & therapeutics 20120101

• The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.

  European journal of clinical pharmacology 20120101

• Granulomatous cutaneous lesions associated with risperidone-induced hyperprolactinemia in an amputated upper limb.

  International journal of dermatology 20120101

• The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.

  General hospital psychiatry 20120101

• Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.

  Journal of medical economics 20120101

• Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.

  Pharmacopsychiatry 20120101

• Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.

  Parkinson's disease 20120101

• Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5.

  Current opinion in psychiatry 20120101

• Hereditary spastic paraplegia and psychosis: connected by the corpus callosum?

  Psychosomatics 20120101

• Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.

  The Journal of clinical psychiatry 20120101

• Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder.

  Drugs 20120101

• Do we really know how to treat a child with bipolar disorder or one with severe mood dysregulation? Is there a magic bullet?

  Depression research and treatment 20120101

• Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.

  Human psychopharmacology 20120101

• Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population.

  Annals of general psychiatry 20120101

• Effects of paliperidone extended release on the symptoms and functioning of schizophrenia.

  BMC clinical pharmacology 20120101

• An efficient synthesis of aripiprazole, buspirone and NAN-190 by the reductive alkylation of amines procedure.

  Archiv der Pharmazie 20120101

• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

  Parkinson's disease 20120101

• Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20120101

• Nowhere patients.

  Psychotherapy and psychosomatics 20120101

• Lycanthropy as a culture-bound syndrome: a case report and review of the literature.

  Journal of psychiatric practice 20120101

• A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).

  Psychotherapy and psychosomatics 20120101

• Tinnitus: network pathophysiology-network pharmacology.

  Frontiers in systems neuroscience 20120101

• Effect of aripiprazole on anxiety associated with ethanol physical dependence and on ethanol-induced place preference.

  Journal of pharmacological sciences 20120101

• Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.

  Frontiers in pharmacology 20120101

• Aripiprazole in the acute and maintenance phase of bipolar I disorder.

  Therapeutics and clinical risk management 20120101

• Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States.

  Journal of medical economics 20120101

• Psychiatric symptoms of patients with primary mitochondrial DNA disorders.

  Behavioral and brain functions : BBF 20120101

• Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties.

  Patient preference and adherence 20120101

• Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.

  BMJ (Clinical research ed.) 20120101

• Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.

  Behavioral and brain functions : BBF 20120101

• Motor agency: a new and highly sensitive measure to reveal agency disturbances in early psychosis.

  PloS one 20120101

• Antipsychotics in pediatric and adolescent patients: a review of comparative safety data.

  Journal of affective disorders 20120101

• Aripiprazole in pediatric psychosis and bipolar disorder: a clinical review.

  Journal of affective disorders 20120101

• Steroid-induced mania treated with aripiprazole.

  Psychosomatics 20120101

• Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.

  PloS one 20120101

• Update on the role of antipsychotics in the treatment of Tourette syndrome.

  Neuropsychiatric disease and treatment 20120101

• Serotonin toxicity in aripiprazole augmentation.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?

  BMC psychiatry 20120101

• Aripiprazole: polymorphs and solvatomorphs.

  Profiles of drug substances, excipients, and related methodology 20120101

• The role of leptin in antipsychotic-induced weight gain: genetic and non-genetic factors.

  Journal of obesity 20120101

• Psychiatric patient and anaesthesia.

  Indian journal of anaesthesia 20120101

• Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review.

  Journal of sex & marital therapy 20120101

• Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia.

  Neuropsychiatric disease and treatment 20120101

• Treatment of refractory catatonic schizophrenia with low dose aripiprazole.

  Annals of general psychiatry 20120101

• Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics.

  PloS one 20120101

• Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Dopamine agonists and pathologic behaviors.

  Parkinson's disease 20120101

• Critical appraisal of lurasidone in the management of schizophrenia.

  Neuropsychiatric disease and treatment 20120101

• Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials.

  Medical gas research 20120101

• Antidopaminergic drugs and acute pancreatitis: a population-based study.

  BMJ open 20120101

• Sudden death of cardiac origin and psychotropic drugs.

  Frontiers in pharmacology 20120101

• Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial.

  Clinical neuropharmacology 20120101

• Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.

  Clinical neuropharmacology 20120101

• Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.

  International journal of general medicine 20120101

• Reduced gray to white matter tissue intensity contrast in schizophrenia.

  PloS one 20120101

• Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.

  PloS one 20120101

• Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders.

  Neural plasticity 20120101

• Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine h(1) receptor blockade.

  Frontiers in psychiatry 20120101

• Unfavorable effects of hyperprolactinemia in autoimmune endocrine disorders.

  Neuro endocrinology letters 20120101

• Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients.

  PloS one 20120101

• Treatment-resistant Schizophrenia: Evidence-based Strategies.

  Mens sana monographs 20120101

• Treatment-resistant depression: therapeutic trends, challenges, and future directions.

  Patient preference and adherence 20120101

• Successful use of add - on topiramate for antipsychotic - induced weight gain.

  Indian journal of psychological medicine 20120101

• A case of intention tremor induced by the combination of aripiprazole and lamotrigine.

  The primary care companion for CNS disorders 20120101

• Altered velocity processing in schizophrenia during pursuit eye tracking.

  PloS one 20120101

• Role of aripiprazole in treatment-resistant schizophrenia.

  Neuropsychiatric disease and treatment 20120101

• Development and validation of an LC-ESI-MS method for quantitative determination of aripiprazole in human plasma and an application to pharmacokinetic study.

  Journal of chromatographic science 20120101

• Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug.

  Annals of general psychiatry 20120101

• Use of aripiprazole in treatment of cannabis dependence in a patient presenting with Borderline Personality Disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Efficacy of aripiprazole in a child with involuntary emotional expression disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Parent report of antidepressant, anxiolytic, and antipsychotic medication use in individuals with Williams syndrome: effectiveness and adverse effects.

  Research in developmental disabilities 20120101

• Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey.

  Health and quality of life outcomes 20120101

• Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.

  The Annals of pharmacotherapy 20120101

• Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses.

  Health economics review 20120101

• Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.

  BMC psychiatry 20120101

• Retrospective study of Japanese patients with schizophrenia treated with aripiprazole.

  ISRN nursing 20120101

• [Useful pharmacologic treatment in impaired social interaction in autism spectrum disorders].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20120101

• [Mood stabilizers in the treatment of bipolar disorder mixed states].

  Rivista di psichiatria 20120101

• Treatment of cerebellar cognitive affective syndrome with aripiprazole.

  Journal of pediatric rehabilitation medicine 20120101

• Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.

  PloS one 20120101

• Aripiprazole reverses paliperidone-induced hyperprolactinemia.

  Actas espanolas de psiquiatria 20120101

• High-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients.

  Drug metabolism and drug interactions 20120101

• Efficacy of adjunctive aripiprazole in major depressive disorder: a pooled response quartile analysis and the predictive value of week 2 early response.

  The primary care companion for CNS disorders 20120101

• Review of the safety of second-generation antipsychotics: are they really 'atypically' safe for youth and adults?

  The primary care companion for CNS disorders 20120101

• Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors.

  European journal of pharmacology 20111205

• Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.

  British journal of clinical pharmacology 20111201

• Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.

  Psychopharmacology 20111201

• Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.

  Psychopharmacology 20111201

• Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20111201

• A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden.

  Nordic journal of psychiatry 20111201

• Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress.

  Neuroscience research 20111201

• Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.

  European child & adolescent psychiatry 20111201

• Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance.

  Current medical research and opinion 20111201

• Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia.

  Journal of clinical psychopharmacology 20111201

• A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo.

  Journal of clinical psychopharmacology 20111201

• Treatments for methamphetamine abuse: a literature review for the clinician.

  Journal of pharmacy practice 20111201

• An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients.

  Palliative & supportive care 20111201

• Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.

  Human psychopharmacology 20111201

• Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.

  Archives of general psychiatry 20111201

• Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.

  Journal of child and adolescent psychopharmacology 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• [Perception of atypical antipsychotics' side effects through speech analysis of schizophrenic patients. TALK Study].

  L'Encephale 20111201

• [Guidelines for the biological treatment of bipolar depression].

  L'Encephale 20111201

• Sundown syndrome in persons with dementia: an update.

  Psychiatry investigation 20111201

• Completion of chronic hepatitis C virus treatment in interferon-induced major depressive disorder with psychotic features.

  Psychiatry investigation 20111201

• Adjunctive aripiprazole for depression: predictive value of early assessment.

  The American journal of managed care 20111201

• A review of obsessive-compulsive disorder in children and adolescents.

  Dialogues in clinical neuroscience 20111201

• [Misuse of alcohol and new drug treatments].

  La Revue du praticien 20111201

• Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.

  Proceedings of the National Academy of Sciences of the United States of America 20111108

• Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.

  Journal of psychopharmacology (Oxford, England) 20111101

• Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.

  Psychological medicine 20111101

• Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents.

  Neurochemistry international 20111101

• Manic induction with interferon alpha therapy.

  The Australian and New Zealand journal of psychiatry 20111101

• Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment.

  Expert review of neurotherapeutics 20111101

• An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20111101

• A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.

  International journal of psychiatry in clinical practice 20111101

• [Potentiation of Aripiprazole extrapiramidal adverse effects with the concomitant use of serotonin selective reuptake inhibitors].

  Revista medica de Chile 20111101

• [Eosinophilic myocarditis and sudden unexpected death in a younger patient treated with antipsychotics].

  Ugeskrift for laeger 20111031

• Effectiveness and safety of antipsychotics in early onset psychoses: a long-term comparison.

  Psychiatry research 20111030

• Optimality, sample size, and power calculations for the sequential parallel comparison design.

  Statistics in medicine 20111015

• In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors.

  European journal of pharmacology 20111015

• An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.

  PLoS currents 20111011

• Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.

  Lancet (London, England) 20111008

• Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study.

  Neuroscience letters 20111003

• Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis.

  Journal of affective disorders 20111001

• Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models.

  The international journal of neuropsychopharmacology 20111001

• Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.

  Synapse (New York, N.Y.) 20111001

• Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats.

  Pharmaceutical research 20111001

• Early detection and management of atypical neuroleptic malignant syndrome secondary to aripiprazole.

  Schizophrenia research 20111001

• Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice.

  Acta pharmacologica Sinica 20111001

• Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

  Journal of clinical psychopharmacology 20111001

• Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment.

  Psychiatry and clinical neurosciences 20111001

• Aripiprazole monotherapy in the treatment of vascular parkinsonism.

  Psychiatry and clinical neurosciences 20111001

• Influence of prenatal undernutrition on the effects of clozapine and aripiprazole in the adult male rats: relevance to a neurodevelopmental origin of schizophrenia?

  European journal of pharmacology 20110930

• Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring?

  European journal of pharmacology 20110930

• Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.

  JAMA 20110928

• Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.

  Journal of medicinal chemistry 20110922

• Adjunctive antipsychotics for major depression.

  The Medical letter on drugs and therapeutics 20110919

• Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain.

  Psychopharmacology 20110901

• The GiSAS study: rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia.

  Contemporary clinical trials 20110901

• Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder.

  Acta psychiatrica Scandinavica 20110901

• Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors.

  European journal of pharmacology 20110901

• A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).

  The American journal of psychiatry 20110901

• CODA-RET reveals functional selectivity as a result of GPCR heteromerization.

  Nature chemical biology 20110901

• Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.

  The Journal of clinical psychiatry 20110901

• Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression.

  Clinical therapeutics 20110901

• Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.

  Schizophrenia bulletin 20110901

• Aripiprazole in the treatment of irritability associated with autistic disorder in paediatric patients: profile report.

  CNS drugs 20110901

• [Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20110901

• Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.

  Psychiatric services (Washington, D.C.) 20110901

• Switching antipsychotic medications: not enough, too often, or just right?

  The American journal of psychiatry 20110901

• Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.

  The American journal of psychiatry 20110901

• Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.

  Psychiatry investigation 20110901

• Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.

  Current neuropharmacology 20110901

• Aripiprazole versus placebo for schizophrenia.

  The Cochrane database of systematic reviews 20110810

• Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110801

• Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.

  The Journal of clinical psychiatry 20110801

• Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study.

  Psychopharmacology 20110801

• Aripiprazole maintenance increases smoked cocaine self-administration in humans.

  Psychopharmacology 20110801

• Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.

  Psychopharmacology 20110801

• Calculating occupancy when one does not have baseline: a comparison of different options.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110801

• Aripiprazole associated hyponatraemia.

  The Australian and New Zealand journal of psychiatry 20110801

• Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110801

• Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole.

  Journal of clinical psychopharmacology 20110801

• Open-label trial of aripiprazole in the treatment of trichotillomania.

  Journal of clinical psychopharmacology 20110801

• A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study).

  Journal of clinical psychopharmacology 20110801

• Changes in the metabolic parameters and QTc interval after switching from olanzapine to aripiprazole in Japanese patients with stable schizophrenia.

  Journal of clinical psychopharmacology 20110801

• Adding aripiprazole to clozapine worsened delusions and hallucinations: a case report.

  Journal of clinical psychopharmacology 20110801

• Aripiprazole and pregnancy: a case report and literature review.

  Journal of clinical psychopharmacology 20110801

• A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients.

  Journal of clinical psychopharmacology 20110801

• Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.

  Drug safety 20110801

• Pathological gambling and the treatment of psychosis with aripiprazole: case reports.

  The British journal of psychiatry : the journal of mental science 20110801

• Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth.

  Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20110801

• Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.

  Journal of child and adolescent psychopharmacology 20110801

• An open-label study of aripiprazole in children with a bipolar disorder.

  Journal of child and adolescent psychopharmacology 20110801

• Relationship between P-glycoprotein and second-generation antipsychotics.

  Pharmacogenomics 20110801

• Safety and tolerability of antipsychotic treatment in young patients with schizophrenia.

  The Journal of clinical psychiatry 20110801

• [A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20110801

• Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost.

  American journal of therapeutics 20110701

• A prospective open-label study of aripiprazole in fragile X syndrome.

  Psychopharmacology 20110701

• Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication.

  Psychopharmacology 20110701

• Species independence in brain tissue binding using brain homogenates.

  Drug metabolism and disposition: the biological fate of chemicals 20110701

• Pharmacokinetics and metabolism update for some recent antipsychotics.

  Expert opinion on drug metabolism & toxicology 20110701

• Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia.

  Schizophrenia research 20110701

• The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone.

  Progress in neuro-psychopharmacology & biological psychiatry 20110701

• A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level.

  Progress in neuro-psychopharmacology & biological psychiatry 20110701

• Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.

  Naunyn-Schmiedeberg's archives of pharmacology 20110701

• Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.

  The Annals of pharmacotherapy 20110701

• Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazole.

  Clinical schizophrenia & related psychoses 20110701

• Issues in the management of challenging behaviours of adults with autism spectrum disorder.

  CNS drugs 20110701

• Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.

  Archives of neurology 20110701

• Psychosis in Parkinson's disease.

  Annals of Indian Academy of Neurology 20110701

• Dementia in parkinsonism.

  Annals of Indian Academy of Neurology 20110701

• Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.

  Behavioural brain research 20110620

• Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety.

  Journal of psychopharmacology (Oxford, England) 20110601

• Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.

  The European journal of health economics : HEPAC : health economics in prevention and care 20110601

• Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis.

  International journal of geriatric psychiatry 20110601

• Aripiprazole versus haloperidol treatment in early-stage schizophrenia.

  Journal of psychiatric research 20110601

• Antipsychotic drug use and community-acquired pneumonia.

  Current infectious disease reports 20110601

• Placental transfer of aripiprazole.

  The Australian and New Zealand journal of psychiatry 20110601

• Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20110601

• Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.

  Paediatric drugs 20110601

• Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.

  Journal of clinical psychopharmacology 20110601

• Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors.

  Journal of clinical psychopharmacology 20110601

• Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.

  Journal of clinical psychopharmacology 20110601

• Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.

  Journal of clinical psychopharmacology 20110601

• Perinatal use of aripiprazole: a case report.

  Journal of clinical psychopharmacology 20110601

• Comment on 'dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia'.

  Journal of clinical psychopharmacology 20110601

• Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound.

  Bioorganic & medicinal chemistry 20110601

• Aripiprazole and haloperidol in the treatment of delirium.

  The Australian and New Zealand journal of psychiatry 20110601

• Emerging drugs for schizophrenia.

  Expert opinion on emerging drugs 20110601

• Adverse effects of oral nonstimulant psychotropic medications in young children reported to a regional poison center.

  Clinical toxicology (Philadelphia, Pa.) 20110601

• The quantitative detection of aripiprazole and its main metabolite by using capillary-electrophoresis.

  Journal of the Chinese Medical Association : JCMA 20110601

• Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.

  Journal of child and adolescent psychopharmacology 20110601

• Low-dose aripiprazole resolved complex hallucinations in the left visual field after right occipital infarction (Charles Bonnet syndrome).

  Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 20110601

• Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia.

  The Indian journal of medical research 20110601

• Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives.

  Dialogues in clinical neuroscience 20110601

• Biomarkers in development of psychotropic drugs.

  Dialogues in clinical neuroscience 20110601

• A case of catatonia and neuroleptic malignant syndrome probably associated with antipsychotic in Korea.

  Psychiatry investigation 20110601

• [Functional homology between alcohol dependence and mood disorder].

  Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20110601

• Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis.

  Journal of psychopharmacology (Oxford, England) 20110501

• Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis.

  Journal of psychopharmacology (Oxford, England) 20110501

• Restless legs syndrome due to aripiprazole.

  European journal of clinical pharmacology 20110501

• A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics.

  International clinical psychopharmacology 20110501

• Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder.

  Bioorganic & medicinal chemistry letters 20110501

• An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.

  Pharmacopsychiatry 20110501

• A systematic review of medical treatments for children with autism spectrum disorders.

  Pediatrics 20110501

• Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20110501

• Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.

  PLoS medicine 20110501

• Use of aripiprazole in adolescents with a history of lupus-associated psychosis and refractory psychiatric manifestations.

  Journal of psychiatric practice 20110501

• Psychosis in Parkinson's disease: therapeutic options.

  Drugs of today (Barcelona, Spain : 1998) 20110501

• Fragile x syndrome.

  Current genomics 20110501

• Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: case reports.

  The International journal of eating disorders 20110401

• All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors.

  CNS neuroscience & therapeutics 20110401

• Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI.

  Community mental health journal 20110401

• Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.

  The Journal of clinical psychiatry 20110401

• Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex.

  Psychopharmacology 20110401

• Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.

  Journal of affective disorders 20110401

• Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.

  Clinical psychology review 20110401

• Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells.

  Neuroscience research 20110401

• Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.

  Schizophrenia research 20110401

• Aripiprazole to treat irritability associated with autism: a placebo-controlled, fixed-dose trial.

  Current psychiatry reports 20110401

• Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice.

  European psychiatry : the journal of the Association of European Psychiatrists 20110401

• Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion.

  Journal of clinical psychopharmacology 20110401

• Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.

  Journal of clinical psychopharmacology 20110401

• Aripiprazole-related acute transient myopia and diplopia: a case report.

  Journal of clinical psychopharmacology 20110401

• Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.

  Advances in therapy 20110401

• European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

  European child & adolescent psychiatry 20110401

• Effectiveness of aripiprazole for medication overuse headache: a case report.

  Psychiatry and clinical neurosciences 20110401

• Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.

  The Journal of clinical psychiatry 20110401

• Newer molecules in the treatment of schizophrenia: A clinical update.

  Indian journal of pharmacology 20110401

• Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.

  Progress in neuro-psychopharmacology & biological psychiatry 20110330

• Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.

  Progress in neuro-psychopharmacology & biological psychiatry 20110330

• A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.

  Progress in neuro-psychopharmacology & biological psychiatry 20110330

• A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.

  Journal of medicinal chemistry 20110324

• Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review.

  International clinical psychopharmacology 20110301

• Three cases of hypomania and one case of mania during aripiprazole treatment.

  Pharmacopsychiatry 20110301

• Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders.

  European child & adolescent psychiatry 20110301

• Aripiprazole for the treatment of irritability associated with autism.

  Expert opinion on pharmacotherapy 20110301

• Olanzapine-induced parkinsonism associated with smoking cessation.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110301

• Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.

  Bipolar disorders 20110301

• Effects of gastrodia elata bl on phencyclidine-induced schizophrenia-like psychosis in mice.

  Current neuropharmacology 20110301

• Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.

  Schizophrenia research 20110201

• Tail suspension test does not detect antidepressant-like properties of atypical antipsychotics.

  Behavioural pharmacology 20110201

• Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.

  Therapeutic drug monitoring 20110201

• Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study.

  Current medical research and opinion 20110201

• Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection.

  Journal of clinical psychopharmacology 20110201

• Micturition difficulty associated with aripiprazole: report of 2 cases.

  Journal of clinical psychopharmacology 20110201

• Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient.

  Journal of clinical psychopharmacology 20110201

• Potential control of risperidone-related cognitive deficits by adjunctive aripiprazole treatment.

  Journal of clinical psychopharmacology 20110201

• Aripiprazole-induced pathological gambling: a report of 3 cases.

  Current drug safety 20110201

• Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.

  CNS drugs 20110201

• Aripiprazole for the treatment of bipolar disorder: a review of current evidence.

  Expert opinion on pharmacotherapy 20110201

• Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series.

  Psychiatry and clinical neurosciences 20110201

• Aripiprazole adjunctive to antidepressant therapy.

  The American journal of psychiatry 20110201

• The role of serotonin receptors in the action of atypical antipsychotic drugs.

  Current opinion in pharmacology 20110201

• Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital.

  Indian journal of pharmacology 20110201

• Aripiprazole protects cortical neurons from glutamate toxicity.

  European journal of pharmacology 20110125

• Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

  Drugs 20110122

• Repetitive administration of aripiprazole enhances locomotor response to methamphetamine in mice.

  Behavioural brain research 20110120

• A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Aripiprazole can treat psychotic features but not motor symptoms of Parkinson's disease: evidence from a SPECT study.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Worsening psychosis after adding aripiprazole to clozapine.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Aripiprazole augmentation induced hypertension in major depressive disorder: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.

  Biological research for nursing 20110101

• Tardive dyskinesia and other movement disorders secondary to aripiprazole.

  Movement disorders : official journal of the Movement Disorder Society 20110101

• Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents.

  Schizophrenia research 20110101

• Switching to aripiprazole as a strategy for weight reduction: a meta-analysis in patients suffering from schizophrenia.

  Journal of obesity 20110101

• Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110101

• Neutropenia associated with quetiapine, olanzapine, and aripiprazole.

  The Australian and New Zealand journal of psychiatry 20110101

• Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.

  Naunyn-Schmiedeberg's archives of pharmacology 20110101

• Second-generation antipsychotics in major depressive disorder: update and clinical perspective.

  Current opinion in psychiatry 20110101

• Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia.

  Current medical research and opinion 20110101

• Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion.

  Pediatrics 20110101

• Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole.

  Addiction biology 20110101

• The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia.

  Expert review of neurotherapeutics 20110101

• If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.

  Drugs 20110101

• One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.

  BMC psychiatry 20110101

• Aripiprazole: striving towards euthymia with a novel mechanism of action.

  Journal of affective disorders 20110101

• Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.

  Journal of affective disorders 20110101

• A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.

  Journal of affective disorders 20110101

• Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder.

  Journal of affective disorders 20110101

• Risperidone versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20110101

• The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders--design of two randomised clinical trials.

  Trials 20110101

• Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.

  BMC psychiatry 20110101

• Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study.

  The American journal on addictions 20110101

• Weight gain, obesity, and psychotropic prescribing.

  Journal of obesity 20110101

• Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).

  Movement disorders : official journal of the Movement Disorder Society 20110101

• Altered small-world brain networks in temporal lobe in patients with schizophrenia performing an auditory oddball task.

  Frontiers in systems neuroscience 20110101

• Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study.

  BMC gastroenterology 20110101

• Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.

  Internal medicine (Tokyo, Japan) 20110101

• Contributions to the study of morphofunctional interrelations in the liver of the rats treated with certain antipsychotic drugs.

  Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20110101

• Phenomenology and treatment of Catatonia: A descriptive study from north India.

  Indian journal of psychiatry 20110101

• Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

  Annals of general psychiatry 20110101

• Paliperidone extended-release: does it have a place in antipsychotic therapy?

  Drug design, development and therapy 20110101

• Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium.

  Annals of general psychiatry 20110101

• Management of Huntington's disease: role of tetrabenazine.

  Therapeutics and clinical risk management 20110101

• Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.

  Handbook of clinical neurology 20110101

• L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study.

  BMC medicine 20110101

• Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system.

  Neuropharmacology 20110101

• Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study.

  Current pharmaceutical design 20110101

• Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review.

  Current pharmaceutical design 20110101

• [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].

  Tijdschrift voor psychiatrie 20110101

• Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia.

  Neuropsychiatric disease and treatment 20110101

• Pharmacotherapy for treatment-resistant schizophrenia.

  Neuropsychiatric disease and treatment 20110101

• Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder.

  Frontiers in psychiatry 20110101

• Anhedonia and substance dependence: clinical correlates and treatment options.

  Frontiers in psychiatry 20110101

• AUTISM Spectrum Disorders and Suicidality.

  Clinical practice and epidemiology in mental health : CP & EMH 20110101

• The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome.

  BMC psychiatry 20110101

• Aripiprazole augmentation in the treatment of military-related PTSD with major depression: a retrospective chart review.

  BMC psychiatry 20110101

• Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.

  BMC psychiatry 20110101

• Antidepressant and antipsychotic use in an Italian pediatric population.

  BMC pediatrics 20110101

• Postural control in bipolar disorder: increased sway area and decreased dynamical complexity.

  PloS one 20110101

• Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.

  Frontiers in psychiatry 20110101

• Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia.

  PloS one 20110101

• Combination of aripiprazole and ethanol attenuates marble-burying behavior in mice.

  Acta poloniae pharmaceutica 20110101

• Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.

  Neuropsychiatric disease and treatment 20110101

• Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence.

  Neuropsychiatric disease and treatment 20110101

• Role of sublingual asenapine in treatment of schizophrenia.

  Neuropsychiatric disease and treatment 20110101

• Advances in understanding and treating ADHD.

  BMC medicine 20110101

• Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence.

  Patient preference and adherence 20110101

• Aripiprazole-related body-weight gain and nutritional counseling.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.

  Clinical practice and epidemiology in mental health : CP & EMH 20110101

• Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

  Journal of pharmacy & bioallied sciences 20110101

• Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.

  BMC psychiatry 20110101

• BioGraph: unsupervised biomedical knowledge discovery via automated hypothesis generation.

  Genome biology 20110101

• A new drug design targeting the adenosinergic system for Huntington's disease.

  PloS one 20110101

• Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.

  Current medicinal chemistry 20110101

• Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.

  The primary care companion for CNS disorders 20110101

• Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies.

  The primary care companion for CNS disorders 20110101

• Aripiprazole in treating a manic episode associated with hydrocephalus: a case report.

  The primary care companion for CNS disorders 20110101

• Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs.

  Frontiers in behavioral neuroscience 20110101

• Clinical potential of lurasidone in the management of schizophrenia.

  Therapeutics and clinical risk management 20110101

• Treatment dilemma in comorbidity of schizophrenia and idiopathic Parkinson's disease.

  General hospital psychiatry 20110101

• Is the PANSS used correctly? a systematic review.

  BMC psychiatry 20110101

• Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy.

  Clinical neuropharmacology 20110101

• Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD.

  Clinical neuropharmacology 20110101

• Successful use of aripiprazole for delusional disorder with comorbid pituitary microadenoma: a case report.

  Psychosomatics 20110101

• [Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences].

  Rivista di psichiatria 20110101

• Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder.

  Patient preference and adherence 20110101

• Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia.

  BMC psychiatry 20110101

• The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia.

  PloS one 20110101

• Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability.

  Depression research and treatment 20110101

• Acute hypersensitivity syndrome caused by valproic Acid: a review of the literature and a case report.

  The Permanente journal 20110101

• A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.

  PloS one 20110101

• Priapism due to a single dose of quetiapine: a case report.

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101

• A Data-Driven Investigation of Gray Matter-Function Correlations in Schizophrenia during a Working Memory Task.

  Frontiers in human neuroscience 20110101

• Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.

  Frontiers in neuroanatomy 20110101

• Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms.

  Frontiers in neuroscience 20110101

• Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy.

  ClinicoEconomics and outcomes research : CEOR 20110101

• A case of bilateral self-induced keratoconus in a patient with tourette syndrome associated with compulsive eye rubbing: case report.

  BMC ophthalmology 20110101

• Improvement of oral dyskinesia after switching from aripiprazole to paliperidone: a case report.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Aripiprazole-associated rhabdomyolysis in a patient with schizophrenia.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.

  Journal of medical economics 20110101

• Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.

  The primary care companion for CNS disorders 20110101

• Altered topological properties of functional network connectivity in schizophrenia during resting state: a small-world brain network study.

  PloS one 20110101

• Alternating hemiplegia in a child misdiagnosed as intractable epilepsy successfully treated with aripiprazole: a case report.

  West African journal of medicine 20110101

• [Rapid tranquillisation; review of the literature and recommendations].

  Tijdschrift voor psychiatrie 20110101

• Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition.

  PloS one 20110101

• Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats.

  Pharmacological reports : PR 20110101

• The management of schizophrenia: focus on extended-release quetiapine fumarate.

  Neuropsychiatric disease and treatment 20110101

• Current management of obsessive and phobic states.

  Neuropsychiatric disease and treatment 20110101

• [Delusional parasitosis associated with dialysis treated with aripiprazole].

  Acta medica portuguesa 20110101

• Management of bipolar depression.

  Indian journal of psychological medicine 20110101

• Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital.

  Indian journal of psychological medicine 20110101

• Inverse agonism and its therapeutic significance.

  Indian journal of pharmacology 20110101

• Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission.

  Frontiers in molecular neuroscience 20110101

• Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors.

  Frontiers in molecular neuroscience 20110101

• Pituitary microadenoma treated with antipsychotic drug aripiprazole.

  Recent patents on endocrine, metabolic & immune drug discovery 20110101

• The treatment of severe child aggression (TOSCA) study: Design challenges.

  Child and adolescent psychiatry and mental health 20110101

• Clinical utility of the risperidone formulations in the management of schizophrenia.

  Neuropsychiatric disease and treatment 20110101

• Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study.

  BMC psychiatry 20110101

• Aripiprazole improves olanzapine-associated obsessive compulsive symptoms in schizophrenia.

  Clinical neuropharmacology 20110101

• The efficacy of low-dose aripiprazole treatment for trichotillomania.

  Clinical neuropharmacology 20110101

• Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study.

  BMC medical research methodology 20110101

• Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians.

  Patient preference and adherence 20110101

• [Evidence of treatment for depressive episodes of bipolar disorder].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20110101

• Resting-state EEG source localization and functional connectivity in schizophrenia-like psychosis of epilepsy.

  PloS one 20110101

• Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder.

  Neuropsychiatric disease and treatment 20110101

• Visible spectrophotometric method for the determination of aripiprazole in tablets.

  Indian journal of pharmaceutical sciences 20110101

• Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports.

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101

• The dopamine hypothesis of drug addiction and its potential therapeutic value.

  Frontiers in psychiatry 20110101

• Identification of major degradation products of ketoconazole.

  Scientia pharmaceutica 20110101

• Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.

  PloS one 20110101

• Antidepressant drug exposure during pregnancy. CZTIS small prospective study.

  Neuro endocrinology letters 20110101

• Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

  BMC psychiatry 20110101

• Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report.

  Case reports in medicine 20110101

• Use of antipsychotic and antidepressant within the Psychiatric Disease Centre, Regional Health Service of Ferrara.

  BMC clinical pharmacology 20110101

• Sexual dysfunction and hyperprolactinemia in male psychotic inpatients: a cross-sectional study.

  Advances in urology 20110101

• Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications.

  Frontiers in psychiatry 20110101

• Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings.

  Frontiers in psychiatry 20110101

• A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population.

  PloS one 20110101

• Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics.

  Patient preference and adherence 20110101

• Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan.

  Patient preference and adherence 20110101

• Modular Organization of Functional Network Connectivity in Healthy Controls and Patients with Schizophrenia during the Resting State.

  Frontiers in systems neuroscience 20110101

• Analysis of Adverse Drug Reactions of Atypical Antipsychotic Drugs in Psychiatry OPD.

  Indian journal of psychological medicine 20110101

• A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole.

  The primary care companion for CNS disorders 20110101

• A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.

  The primary care companion for CNS disorders 20110101

• Impulse control loss rapidly reversed by aripiprazole in a patient with concomitant bipolar disease type I and posttraumatic frontal lobe lesions.

  BMJ case reports 20110101

• Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.

  BMJ case reports 20110101

• A Chromatographic Determination of Aripiprazole using HPLC and UPLC: A Comparative Validation Study.

  Indian journal of pharmaceutical sciences 20110101

• [Hyperprolactinemia in mentally ill patients].

  Acta medica portuguesa 20110101

• Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophrenia.

  Case reports in psychiatry 20110101

• Delusional parasitosis of face in a factory worker.

  Industrial psychiatry journal 20110101

• An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

  Human psychopharmacology 20110101

• Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.

  The Cochrane database of systematic reviews 20101208

• Second-generation antipsychotics for major depressive disorder and dysthymia.

  The Cochrane database of systematic reviews 20101208

• Compliance with atypical antipsychotic triage guidelines by Texas poison centers.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20101201

• No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20101201

• Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.

  Progress in neuro-psychopharmacology & biological psychiatry 20101201

• The effect of coadministration of duloxetine on steady-state serum concentration of risperidone and aripiprazole: a study based on therapeutic drug monitoring data.

  Therapeutic drug monitoring 20101201

• Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials.

  Journal of clinical psychopharmacology 20101201

• Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20101201

• Therapeutic potential of new second generation antipsychotics for major depressive disorder.

  Expert opinion on investigational drugs 20101201

• Aripiprazole as a viable alternative for treating delusions of parasitosis.

  Journal of drugs in dermatology : JDD 20101201

• New-onset psychosis and emergence of suicidal ideation with aripiprazole.

  The American journal of psychiatry 20101201

• Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.

  Assay and drug development technologies 20101201

• Temporomandibular dislocation due to aripiprazole induced dystonia.

  British journal of clinical pharmacology 20101201

• Pharmacotherapeutics of Tourette syndrome and stereotypies in autism.

  Seminars in pediatric neurology 20101201

• Acute akathisia with quetiapine: A case report and review of literature.

  Indian journal of pharmacology 20101201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101201

• Deficits in facial emotion recognition in schizophrenia: a replication study with korean subjects.

  Psychiatry investigation 20101201

• Brain serotonergic circuitries.

  Dialogues in clinical neuroscience 20101201

• Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

  Healthcare informatics research 20101201

• Successful drug development despite adverse preclinical findings part 2: examples.

  Journal of toxicologic pathology 20101201

• Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouse.

  Neuroscience 20101124

• Partial agonist therapy in schizophrenia: relevance to diminished criminal responsibility.

  Journal of forensic sciences 20101101

• A systematic review of aripiprazole--dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring.

  The Journal of clinical psychiatry 20101101

• Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice.

  Neuropharmacology 20101101

• Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

  Schizophrenia research 20101101

• A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007).

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101101

• Advances in the treatment of psychiatric disorders in long-term care homes.

  Current opinion in psychiatry 20101101

• Treatment of tics and tourette syndrome.

  Current treatment options in neurology 20101101

• Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders.

  Current treatment options in neurology 20101101

• Epidemiologic study of aripiprazole use and the incidence of suicide events.

  Pharmacoepidemiology and drug safety 20101101

• Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir.

  The Annals of pharmacotherapy 20101101

• A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.

  Journal of separation science 20101101

• Use of aripiprazole in a patient with multiple sclerosis presenting with paranoid psychosis.

  Journal of psychiatric practice 20101101

• Management of a patient with schizophrenia and underlying pituitary macroadenoma.

  Annals of the Academy of Medicine, Singapore 20101101

• Quetiapine in the treatment of psychosis in Parkinson's disease.

  Therapeutic advances in neurological disorders 20101101

• A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia.

  Psychiatry (Edgmont (Pa. : Township)) 20101101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101101

• The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20101101

• Neuroleptic malignant syndrome with aripiprazole in Huntington's disease.

  Movement disorders : official journal of the Movement Disorder Society 20101030

• RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ).

  CNS neuroscience & therapeutics 20101001

• Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks.

  European archives of psychiatry and clinical neuroscience 20101001

• Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature.

  Archives of women's mental health 20101001

• The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.

  The Journal of clinical psychiatry 20101001

• Delusional infestation: neural correlates and antipsychotic therapy investigated by multimodal neuroimaging.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• A case of Cotard's Syndrome successfully treated with aripiprazole monotherapy.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.

  Psychopharmacology 20101001

• Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.

  Psychopharmacology 20101001

• Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase.

  Journal of neural transmission (Vienna, Austria : 1996) 20101001

• Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics.

  Bioorganic & medicinal chemistry letters 20101001

• Treatment options for bipolar depression: a systematic review of randomized, controlled trials.

  Journal of clinical psychopharmacology 20101001

• Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.

  Journal of clinical psychopharmacology 20101001

• Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010).

  Journal of clinical psychopharmacology 20101001

• Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.

  Neurocase 20101001

• Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report.

  Clinical schizophrenia & related psychoses 20101001

• Treatment with antipsychotics and the risk of diabetes in clinical practice.

  The British journal of psychiatry : the journal of mental science 20101001

• Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

  Journal of child and adolescent psychopharmacology 20101001

• Novel 7-phenylsulfanyl-1,2,3,4,10,10a-hexahydro-pyrazino[1,2-a]indoles as dual serotonin 5-HT2C and 5-HT6 receptor ligands.

  Bioorganic & medicinal chemistry letters 20100915

• Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures.

  Neuroscience letters 20100906

• Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.

  The international journal of neuropsychopharmacology 20100901

• Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.

  The Journal of clinical psychiatry 20100901

• Self-injurious behaviour in people with intellectual disability.

  Current opinion in psychiatry 20100901

• Treatment of Irritability in Huntington's Disease.

  Current treatment options in neurology 20100901

• The need for a long-term perspective in child and adolescent psychiatry.

  European child & adolescent psychiatry 20100901

• Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.

  Pharmacotherapy 20100901

• Management of neuropsychiatric symptoms in people with dementia.

  CNS drugs 20100901

• Efficacy and tolerability of aripiprazole: a 26-week switching study from oral antipsychotics.

  Psychiatry investigation 20100901

• Retrospective case series of aripiprazole augmentation in pervasive developmental disorders.

  Psychiatry investigation 20100901

• Pharmacologic treatment of schizophrenia.

  Dialogues in clinical neuroscience 20100901

• Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.

  Dialogues in clinical neuroscience 20100901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100901

• Antiepileptic drug interactions - principles and clinical implications.

  Current neuropharmacology 20100901

• Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport.

  European journal of pharmacology 20100825

• Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Aripiprazole monotherapy in a patient with major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Treatment of schizophreniform disorder by aripiprazole in a female adolescent with 22q11.2 deletion syndrome.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Aripiprazole attenuates established behavioral sensitization induced by methamphetamine.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Delusional parasitosis in a patient with brain atrophy and renal failure treated with aripiprazole: case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.

  Synapse (New York, N.Y.) 20100801

• Aripiprazole add-on treatment in a patient with schizoaffective disorder: neurocognitive outcomes.

  Pharmacopsychiatry 20100801

• Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100801

• The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics.

  Journal of clinical psychopharmacology 20100801

• Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers.

  Journal of clinical psychopharmacology 20100801

• Aripiprazole-related subcortical growth in a patient with major depressive disorder and panic disorder.

  Journal of clinical psychopharmacology 20100801

• What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?

  Journal of clinical psychopharmacology 20100801

• Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100801

• Simultaneous determination of aripiprazole and its active metabolite, dehydroaripiprazole, in plasma by capillary electrophoresis combining on-column field-amplified sample injection and application in schizophrenia.

  Electrophoresis 20100801

• Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.

  Journal of child and adolescent psychopharmacology 20100801

• Management of hallucinations and psychosis in Parkinson's disease.

  The American journal of geriatric pharmacotherapy 20100801

• Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole.

  Psychiatry research 20100730

• Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.

  Journal of psychopharmacology (Oxford, England) 20100701

• Pharmacotherapy of bipolar disorder in children and adolescents: recent progress.

  CNS drugs 20100701

• The impact of perfectionism and anxiety traits on action monitoring in major depressive disorder.

  Journal of neural transmission (Vienna, Austria : 1996) 20100701

• Atypical antipsychotic metabolism and excretion.

  Current drug metabolism 20100701

• Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia.

  Schizophrenia research 20100701

• The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives.

  Current opinion in investigational drugs (London, England : 2000) 20100701

• Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depression.

  Current opinion in investigational drugs (London, England : 2000) 20100701

• Diabetic ketoacidosis and elevated serum lipase in the setting of aripiprazole therapy.

  Diabetes care 20100701

• [Aripiprazole - a medical treatment alternative for Tourette Syndrome in childhood and adolescence].

  Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20100701

• Aripiprazole in autism spectrum disorders and fragile X syndrome.

  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20100701

• Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed.

  Postgraduate medicine 20100701

• Real-world Data on Atypical Antipsychotic Medication Side Effects.

  Psychiatry (Edgmont (Pa. : Township)) 20100701

• Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptors.

  Journal of medicinal chemistry 20100624

• Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents.

  Journal of psychiatric research 20100601

• Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

  CNS neuroscience & therapeutics 20100601

• Hyperprolactinaemia during treatment with paliperidone.

  Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20100601

• Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.

  Current medical research and opinion 20100601

• A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole.

  Journal of clinical psychopharmacology 20100601

• Clozapine-associated cerebral venous thrombosis.

  Journal of clinical psychopharmacology 20100601

• Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia.

  International journal of clinical pharmacology and therapeutics 20100601

• Differences of clinical characteristics and phenotypes between prepubertal- and adolescent-onset bipolar disorders.

  Journal of Korean medical science 20100601

• Antipsychotic dosing: still a work in progress.

  The American journal of psychiatry 20100601

• Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.

  American family physician 20100601

• The contribution of abdominal obesity and dyslipidemia to metabolic syndrome in psychiatric patients.

  The Korean journal of internal medicine 20100601

• [A control study of aripiprazole and tiapride treatment for tic disorders in children].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20100601

• Changes in values of cholesterol and tryglicerides after weight loss during treatment with aripiprazole in a patient with schizophrenia - Case report.

  Psychiatria Danubina 20100601

• Pharmacological approaches to methamphetamine dependence: a focused review.

  British journal of clinical pharmacology 20100601

• Predictive factors of social functioning in patients with schizophrenia: exploration for the best combination of variables using data mining.

  Psychiatry investigation 20100601

• Antipsychotic effects of quetiapine in naturalistic long term follow up study.

  Psychiatry investigation 20100601

• Case of tardive dystonia improved by aripiprazole.

  Psychiatry and clinical neurosciences 20100601

• [Long-term (prophylactic) therapy of bipolar patients with aripiprazole].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100601

• [Use of aripiprazole in the treatment of catatonia].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100601

• [Metabolic side effects of risperidone in early onset schizophrenia].

  L'Encephale 20100601

• Drug treatment of obsessive-compulsive disorder.

  Dialogues in clinical neuroscience 20100601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100601

• Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report.

  Journal of pharmacy practice 20100601

• Drug-induced Pisa syndrome associated with aripiprazole during clozapine treatment.

  Progress in neuro-psychopharmacology & biological psychiatry 20100530

• Aripiprazole augmentation for the treatment of an adolescent with posttraumatic stress disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20100530

• Treatment of tardive dyskinesia with aripiprazole.

  Neurotoxicity research 20100501

• Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting.

  The international journal of neuropsychopharmacology 20100501

• Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.

  The international journal of neuropsychopharmacology 20100501

• The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

  Behavioural brain research 20100501

• Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.

  Schizophrenia research 20100501

• Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes.

  Naunyn-Schmiedeberg's archives of pharmacology 20100501

• Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.

  Journal of neural transmission (Vienna, Austria : 1996) 20100501

• Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.

  Expert review of neurotherapeutics 20100501

• Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient.

  The Journal of clinical psychiatry 20100501

• Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.

  Clinical neuropharmacology 20100501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100501

• Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.

  Sao Paulo medical journal = Revista paulista de medicina 20100501

• Review: is aripiprazole as effective as risperidone in people with schizophrenia?

  Evidence-based mental health 20100501

• Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.

  Toxicology 20100411

• The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.

  Journal of psychopharmacology (Oxford, England) 20100401

• Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.

  The Journal of pharmacology and experimental therapeutics 20100401

• Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia.

  Psychopharmacology 20100401

• Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.

  The Annals of pharmacotherapy 20100401

• Restless leg syndrome associated with olanzapine: a case series.

  Current drug safety 20100401

• Rapid response to antipsychotic treatment on psychotic prodrome: implications from a case series.

  Psychiatry and clinical neurosciences 20100401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100401

• [Action of amygdala dopamine and effect of antipsychotics].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401

• First manic episode in a 55-year-old man after initiation of aripiprazole.

  Psychiatry (Edgmont (Pa. : Township)) 20100401

• Aripiprazole in pregnancy and lactation: a case report.

  Journal of clinical psychopharmacology 20100401

• Dopamine D2 receptors as treatment targets in schizophrenia.

  Clinical schizophrenia & related psychoses 20100401

• Switching and combining antipsychotics.

  CNS spectrums 20100401

• Advances in the pharmacological management of Huntington's disease.

  Drugs 20100326

• Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).

  Journal of medicinal chemistry 20100325

• Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics.

  Progress in neuro-psychopharmacology & biological psychiatry 20100317

• Neuroleptic malignant syndrome with the addition of aripiprazole to clozapine.

  Progress in neuro-psychopharmacology & biological psychiatry 20100317

• The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.

  Bioorganic & medicinal chemistry letters 20100315

• Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation.

  Schizophrenia bulletin 20100301

• Aripiprazole-induced rabbit syndrome: a case report.

  Journal of psychopharmacology (Oxford, England) 20100301

• Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task.

  Brain topography 20100301

• Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia.

  Pharmacology, biochemistry, and behavior 20100301

• The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia.

  Human psychopharmacology 20100301

• Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.

  Journal of neurochemistry 20100301

• The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100301

• Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.

  Bioorganic & medicinal chemistry 20100301

• Pathological gambling and compulsive eating associated with aripiprazole.

  The Australian and New Zealand journal of psychiatry 20100301

• Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone.

  Human psychopharmacology 20100301

• Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.

  Human psychopharmacology 20100301

• Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.

  Human psychopharmacology 20100301

• Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence.

  CNS & neurological disorders drug targets 20100301

• Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

• Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

• Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

• [Difficulties in changing drugs--from clozapine to aripiprazole in ambulatory care].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100301

• Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder.

  The Journal of clinical psychiatry 20100301

• Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.

  Pharmacopsychiatry 20100301

• Psychiatric pharmacogenomic testing in clinical practice.

  Dialogues in clinical neuroscience 20100301

• Systematic reviews of assessment measures and pharmacologic treatments for agitation.

  Clinical therapeutics 20100301

• Warning on treating depression.

  Medicine and health, Rhode Island 20100301

• Antipsychotics in pregnancy.

  Journal of psychiatric and mental health nursing 20100301

• Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway.

  Neuroscience letters 20100226

• Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.

  Journal of affective disorders 20100201

• Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.

  The international journal of neuropsychopharmacology 20100201

• Serious generalized tonic-clonic seizures induced by aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20100201

• Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance.

  Current opinion in pharmacology 20100201

• Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study.

  Psychiatry and clinical neurosciences 20100201

• Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

  Psychopharmacology 20100201

• Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity.

  Journal of clinical psychopharmacology 20100201

• Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.

  Journal of clinical psychopharmacology 20100201

• Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar I disorder patient.

  Journal of clinical psychopharmacology 20100201

• Therapeutic options for treatment-resistant depression.

  CNS drugs 20100201

• Use of aripiprazole in clozapine induced enuresis: report of two cases.

  Journal of Korean medical science 20100201

• Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.

  Psychiatric services (Washington, D.C.) 20100201

• Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data.

  Journal of child and adolescent psychopharmacology 20100201

• Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.

  Early intervention in psychiatry 20100201

• Trial of aripiprazole in the treatment of first-episode schizophrenia.

  Psychiatry and clinical neurosciences 20100201

• Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.

  Psychiatry and clinical neurosciences 20100201

• Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia.

  Indian journal of pharmacology 20100201

• Zotepine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100120

• Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.

  NeuroImage 20100101

• Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.

  Journal of affective disorders 20100101

• The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100101

• WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.

  The Journal of pharmacology and experimental therapeutics 20100101

• Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100101

• No influence of FAT polymorphisms in response to aripiprazole.

  Journal of human genetics 20100101

• Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

  Current pharmaceutical design 20100101

• Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.

  Pharmacology & therapeutics 20100101

• Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.

  The British journal of psychiatry : the journal of mental science 20100101

• Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.

  Archives of general psychiatry 20100101

• Amisulpride versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• Quetiapine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.

  PloS one 20100101

• The role of aripiprazole in Canada: A review of clinical and drug discontinuation data. Foreword.

  Clinical therapeutics 20100101

• Aripiprazole in schizophrenia and schizoaffective disorder: A review.

  Clinical therapeutics 20100101

• Aripiprazole for the maintenance treatment of bipolar I disorder: A review.

  Clinical therapeutics 20100101

• Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study.

  Clinical drug investigation 20100101

• Aripiprazole, hypertension, and confusion.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• First-generation vs second-generation antipsychotic drugs: The ongoing saga.

  Indian journal of psychiatry 20100101

• [Disappearance of paroxysmal perceptual alteration by switching to aripiprazole in a schizophrenic patient].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20100101

• Identification of molecular targets associated with ethanol toxicity and implications in drug development.

  Current pharmaceutical design 20100101

• Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.

  Annals of general psychiatry 20100101

• Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.

  PloS one 20100101

• Second-generation antipsychotics cause weight gain in youths.

  The Harvard mental health letter 20100101

• Controversies concerning the diagnosis and treatment of bipolar disorder in children.

  Child and adolescent psychiatry and mental health 20100101

• Olanzapine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• The successful treatment of disinhibition due to a possible case of non-human immunodeficiency virus neurosyphilis: a proposed pathophysiological explanation of the symptoms and treatment.

  General hospital psychiatry 20100101

• Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism.

  Neuropsychiatric disease and treatment 20100101

• Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.

  Neuropsychiatric disease and treatment 20100101

• New atypical antipsychotics for schizophrenia: iloperidone.

  Drug design, development and therapy 20100101

• Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression.

  Case reports in medicine 20100101

• Optimization of aripiprazole synthesis.

  Acta poloniae pharmaceutica 20100101

• Tetrabenazine is neuroprotective in Huntington's disease mice.

  Molecular neurodegeneration 20100101

• Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder.

  Chang Gung medical journal 20100101

• Medications acting on the dopaminergic system in the treatment of alcoholic patients.

  Current pharmaceutical design 20100101

• Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine.

  PloS one 20100101

• Middle and Late Latency ERP Components Discriminate between Adults, Typical Children, and Children with Sensory Processing Disorders.

  Frontiers in integrative neuroscience 20100101

• Anticholinergic use in children and adolescents after initiation of antipsychotic therapy.

  The Annals of pharmacotherapy 20100101

• Pharmacotherapy and the risk for community-acquired pneumonia.

  BMC geriatrics 20100101

• Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.

  PharmacoEconomics 20100101

• S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

  Cardiovascular psychiatry and neurology 20100101

• Comments on 'Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials'.

  General hospital psychiatry 20100101

• Augmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot study.

  Clinical practice and epidemiology in mental health : CP & EMH 20100101

• Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

  Frontiers in neuroscience 20100101

• Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder.

  Clinical drug investigation 20100101

• Factors associated with dental caries among institutionalized residents with schizophrenia in Taiwan: a cross-sectional study.

  BMC public health 20100101

• Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.

  BMC psychiatry 20100101

• Clinical pharmacology and vascular risk.

  The open neurology journal 20100101

• Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.

  BMC psychiatry 20100101

• No influence of DTNBP1 polymorphisms on the response to aripiprazole.

  Neuropsychobiology 20100101

• Lithium, trifluperazine and idiopathic leucopenia: Author and reviewer perspectives on how to write a good case report.

  Indian journal of psychiatry 20100101

• A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting.

  Annals of general psychiatry 20100101

• Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.

  General hospital psychiatry 20100101

• Aripiprazole for late-life schizophrenia.

  Clinical interventions in aging 20100101

• Getting the balance right: Established and emerging therapies for major depressive disorders.

  Neuropsychiatric disease and treatment 20100101

• Emerging role of sertindole in the management of schizophrenia.

  Neuropsychiatric disease and treatment 20100101

• Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection.

  Neuropsychiatric disease and treatment 20100101

• Emerging treatments in the management of schizophrenia - focus on sertindole.

  Drug design, development and therapy 20100101

• Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse.

  Neuropsychiatric disease and treatment 20100101

• Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence.

  Patient preference and adherence 20100101

• Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection.

  Patient preference and adherence 20100101

• Acyclovir nephrotoxicity: a case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy.

  Case reports in medicine 20100101

• Hyperprolactinemia with antipsychotic drugs in children and adolescents.

  International journal of pediatric endocrinology 20100101

• Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.

  BMC psychiatry 20100101

• Exploratory analysis of psychiatric-related utilization and costs associated with paliperidone ER compared with other oral atypical antipsychotics using pharmacy claims from an administrative database.

  Journal of medical economics 20100101

• Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.

  Clinical drug investigation 20100101

• Zotepine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole.

  Actas espanolas de psiquiatria 20100101

• Pharmaceutical treatment of acute bipolar depression.

  F1000 medicine reports 20100101

• Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension.

  Neuropsychiatric disease and treatment 20100101

• Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.

  Neuropsychiatric disease and treatment 20100101

• Role of paliperidone extended-release in treatment of schizoaffective disorder.

  Neuropsychiatric disease and treatment 20100101

• Aripiprazole treatment for coprophagia in autistic disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder.

  BMC psychiatry 20100101

• Patient perspectives on antipsychotic treatments and their association with clinical outcomes.

  Patient preference and adherence 20100101

• Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet.

  Psychosomatics 20100101

• Choreoathetosis in the setting of lithium toxicity.

  Psychosomatics 20100101

• Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.

  Psychopharmacology bulletin 20100101

• Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.

  Psychopharmacology bulletin 20100101

• Clozapine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• New insights in the management of antipsychotics in the treatment of schizophrenia in a patient with prolactinoma: a case report and review of the literature.

  Case reports in medicine 20100101

• Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.

  Neuropsychiatric disease and treatment 20100101

• Off-label second generation antipsychotics for impulse regulation disorders: a review.

  Psychopharmacology bulletin 20100101

• Prescription drugs associated with reports of violence towards others.

  PloS one 20100101

• [The quest for the pharmacological treatment of schizophrenia: from conventional neuroleptics to atypical antipsychotics and beyond].

  Vertex (Buenos Aires, Argentina) 20100101

• Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report.

  Psychopharmacology bulletin 20100101

• A Case of Treatment Resistant Depression and Alcohol Abuse in a Person with Mental Retardation: Response to Aripiprazole and Fluvoxamine Therapy upon Consideration of a Bipolar Diathesis after Repetitive Failure to Respond to Multiple Antidepressant Trials.

  Case reports in medicine 20100101

• The geriatric population and psychiatric medication.

  Mens sana monographs 20100101

• Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management.

  Mens sana monographs 20100101

• [Efficacy of aripiprazole on patients with at-risk mental state and subjective well-being].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20100101

• Safety and tolerability of antipsychotics: focus on amisulpride.

  Drug, healthcare and patient safety 20100101

• Asenapine, a new sublingual atypical antipsychotic.

  Journal of pharmacology & pharmacotherapeutics 20100101

• An overview of Indian research in schizophrenia.

  Indian journal of psychiatry 20100101

• Research on antipsychotics in India.

  Indian journal of psychiatry 20100101

• Incontinence and mood disorder: is there an association?

  BMJ case reports 20100101

• The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain.

  Neuroscience 20091229

• Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS.

  Journal of pharmaceutical and biomedical analysis 20091205

• Very high-dose clozapine and electroconvulsive therapy combination treatment in a patient with schizophrenia.

  The journal of ECT 20091201

• Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats.

  Neurochemistry international 20091201

• In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).

  The Journal of pharmacology and experimental therapeutics 20091201

• Duration of pharmacotherapy with long-acting injectable risperidone in the treatment of schizophrenia.

  The Psychiatric quarterly 20091201

• Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse.

  Psychopharmacology 20091201

• Antipsychotic effects on auditory sensory gating in schizophrenia patients.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091201

• Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20091201

• Successful aripiprazole augmentation in a child with drug-resistant obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20091201

• Myxedema coma associated with combination aripiprazole and sertraline therapy.

  The Annals of pharmacotherapy 20091201

• Improvement in social competence in patients with schizophrenia: a pilot study using a performance-based measure using virtual reality.

  Human psychopharmacology 20091201

• Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

  Pediatrics 20091201

• Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

  CNS drugs 20091201

• Pediatric bipolar disorder.

  Journal of psychosocial nursing and mental health services 20091201

• Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.

  Prescrire international 20091201

• Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.

  Journal of child and adolescent psychopharmacology 20091201

• [Aripiprazole-induced stuttering treated with risperidone].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20091201

• The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.

  Clinical therapeutics 20091201

• Pharmacogenetics of antipsychotic-induced side effects.

  Dialogues in clinical neuroscience 20091201

• Comparative Analysis of Cognitive Function in Schizophrenia with and without Obsessive Compulsive Disorder.

  Psychiatry investigation 20091201

• Improvement of restless legs syndrome and trichotillomania with aripiprazole.

  Journal of clinical pharmacy and therapeutics 20091201

• Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.

  European journal of pharmacology 20091125

• Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20091113

• Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.

  Behavioural brain research 20091105

• Asenapine effects in animal models of psychosis and cognitive function.

  Psychopharmacology 20091101

• A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

  Journal of the American Academy of Child and Adolescent Psychiatry 20091101

• [Tics and Tourette's syndrome throughout the life span].

  Der Nervenarzt 20091101

• Diagnosis and treatment of comorbidities of Tourette's syndrome and bipolar disorder in a 10-year-old boy.

  The Kaohsiung journal of medical sciences 20091101

• Packages of care for dementia in low- and middle-income countries.

  PLoS medicine 20091101

• Effectiveness of intramuscular aripiprazole injection in patients with catatonia: report on three cases.

  Pharmacopsychiatry 20091101

• Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.

  Journal of psychiatric practice 20091101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091101

• Mixed episodes with psychotic features.

  CNS spectrums 20091101

• Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

  JAMA 20091028

• Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20091001

• Reversible Pisa syndrome associated with switching from haloperidol to aripiprazole during lithium treatment.

  Progress in neuro-psychopharmacology & biological psychiatry 20091001

• Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.

  Psychopharmacology 20091001

• Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.

  Pharmacoepidemiology and drug safety 20091001

• Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia.

  Therapeutic drug monitoring 20091001

• Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.

  The international journal of neuropsychopharmacology 20091001

• Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole.

  Journal of clinical pharmacy and therapeutics 20091001

• Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental state.

  Journal of clinical psychopharmacology 20091001

• Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder.

  Journal of clinical psychopharmacology 20091001

• Asymptomatic hyperamylasemia and hyperlipasemia associated with aripiprazole.

  Journal of clinical psychopharmacology 20091001

• A case of aripiprazole-associated paroxysmal supraventricular tachycardia.

  Journal of clinical psychopharmacology 20091001

• [Aripiprazole induced Parkinsonism: A case report].

  L'Encephale 20091001

• Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.

  Journal of child and adolescent psychopharmacology 20091001

• Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.

  Journal of child and adolescent psychopharmacology 20091001

• Clozapine-aripiprazole association in a 7-year-old girl with schizophrenia: clinical efficacy and successful management of neutropenia with lithium.

  Journal of child and adolescent psychopharmacology 20091001

• Aripiprazole and hypertension in adolescents.

  Journal of child and adolescent psychopharmacology 20091001

• A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.

  The Journal of clinical psychiatry 20091001

• Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders.

  The Journal of clinical psychiatry 20091001

• Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.

  The Journal of clinical psychiatry 20091001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091001

• Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome.

  Biological psychiatry 20090915

• Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.

  Psychopharmacology 20090901

• The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.

  Pharmacoepidemiology and drug safety 20090901

• Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications.

  Current drug safety 20090901

• Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.

  International clinical psychopharmacology 20090901

• Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.

  CNS drugs 20090901

• [A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists].

  Annales pharmaceutiques francaises 20090901

• [Diabetes and second-generation (atypical) antipsychotics].

  Annales d'endocrinologie 20090901

• Effects of some antipsychotics and a benzodiazepine hypnotic on the sleep-wake pattern in an animal model of schizophrenia.

  Journal of pharmacological sciences 20090901

• Therapy and quality of life of patients with psychosis.

  Psychiatria Danubina 20090901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090901

• Psychiatric disorder in two siblings with hallervorden-spatz disease.

  Psychiatry investigation 20090901

• The use of aripiprazole in early onset schizophrenia: safety and efficacy.

  The Medical journal of Malaysia 20090901

• Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.

  Neuroscience letters 20090821

• Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.

  The international journal of neuropsychopharmacology 20090801

• Advancing radiology through informed leadership: summary of the proceedings of the Seventh Biannual Symposium of the International Society for Strategic Studies in Radiology (IS(3)R), 23-25 August 2007.

  European radiology 20090801

• Influence of TAAR6 polymorphisms on response to aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20090801

• HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients.

  Psychopharmacology 20090801

• Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090801

• Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.

  European journal of pharmacology 20090801

• A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol.

  Human psychopharmacology 20090801

• Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.

  Schizophrenia research 20090801

• Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies.

  Journal of clinical psychopharmacology 20090801

• Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study.

  Journal of clinical psychopharmacology 20090801

• Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive-compulsive disorder.

  Psychiatry and clinical neurosciences 20090801

• Using oral ziprasidone effectively: the food effect and dose-response.

  Advances in therapy 20090801

• An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.

  Journal of child and adolescent psychopharmacology 20090801

• Open label aripiprazole in the treatment of youth with tic disorders.

  Journal of child and adolescent psychopharmacology 20090801

• Focus on aripiprazole: a review of its use in child and adolescent psychiatry.

  Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20090801

• Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials.

  Journal of psychopharmacology (Oxford, England) 20090701

• Spatio-temporal clusters of new psychotropic medications among Michigan children insured by Medicaid.

  Pharmacoepidemiology and drug safety 20090701

• Treatment of catatonic schizophrenia with lorazepam and aripiprazole.

  Schizophrenia research 20090701

• A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder.

  International clinical psychopharmacology 20090701

• Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.

  Journal of neural transmission (Vienna, Austria : 1996) 20090701

• Aripiprazole for the treatment of agitation in persons with dementia?

  Journal of the American Medical Directors Association 20090701

• Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review.

  Pharmacopsychiatry 20090701

• Aripiprazole for the management of olanzapine-induced weight gain.

  Pharmacopsychiatry 20090701

• Risk assessment of isolated aripiprazole exposures and toxicities: a retrospective study.

  Clinical toxicology (Philadelphia, Pa.) 20090701

• A multiattribute decision model for bipolar disorder: identification of preferred mood-stabilizing medications.

  The American journal of managed care 20090701

• Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review.

  The Journal of clinical psychiatry 20090701

• Aripiprazole treatment of risperidone-induced hyperprolactinemia.

  The Journal of clinical psychiatry 20090701

• Courses of aripiprazole-associated tardive dyskinesia: report of two cases.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Supersensitivity psychosis and aripiprazole tapering.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications.

  Journal of pharmaceutical sciences 20090601

• Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.

  Diabetes care 20090601

• UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).

  European archives of psychiatry and clinical neuroscience 20090601

• The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics.

  The international journal of neuropsychopharmacology 20090601

• Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.

  The Journal of clinical psychiatry 20090601

• Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study.

  Journal of clinical psychopharmacology 20090601

• Aripiprazole augmentation for a patient with partial remission of panic disorder.

  Journal of clinical psychopharmacology 20090601

• [Atypical antipsychotic efficacy and safety in managing delirium: a systematic review and critical analysis].

  Psychologie & neuropsychiatrie du vieillissement 20090601

• [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].

  Therapeutische Umschau. Revue therapeutique 20090601

• A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.

  The American journal of emergency medicine 20090601

• Olfactory disturbance in Parkinson disease.

  Archives of neurology 20090601

• Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

  Journal of child and adolescent psychopharmacology 20090601

• Aripiprazole treatment of psychosis in a child with posterior fossa retrocerebellar arachnoid cyst.

  Journal of child and adolescent psychopharmacology 20090601

• Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.

  Journal of medical economics 20090601

• Antipsychotic agents in the treatment of bipolar mania.

  Bipolar disorders 20090601

• Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic.

  Prescrire international 20090601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090601

• A liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitation of aripiprazole in human plasma.

  Journal of analytical toxicology 20090601

• Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.

  Clinical therapeutics 20090601

• Anhedonia and ambivalence in schizophrenic patients with fronto-cerebellar metabolic abnormalities: a fluoro-d-glucose positron emission tomography study.

  Psychiatry investigation 20090601

• Atypical antipsychotic drugs and the risk of sudden cardiac death.

  The New England journal of medicine 20090514

• A UK consensus on the administration of aripiprazole for the treatment of mania.

  Journal of psychopharmacology (Oxford, England) 20090501

• Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090501

• The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.

  Journal of affective disorders 20090501

• Aripiprazole brain concentration is altered in P-glycoprotein deficient mice.

  Schizophrenia research 20090501

• Comparing the effectiveness of aripiprazole and quetiapine in schizophrenia and related psychoses: a naturalistic, retrospective chart review study.

  The Journal of clinical psychiatry 20090501

• Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning.

  International clinical psychopharmacology 20090501

• Akathisia and second-generation antipsychotic drugs.

  Current opinion in psychiatry 20090501

• Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder.

  Evidence-based mental health 20090501

• Refractory schizophrenia: adding aripiprazole to clozapine reduces negative but not overall symptoms.

  Evidence-based mental health 20090501

• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

  Bipolar disorders 20090501

• Update on neuropsychiatric symptoms of dementia: antipsychotic use.

  Geriatrics 20090501

• Psychosocial functioning in patients with schizophrenia treated with aripiprazole - an office-based real-world setting. Results from the German post-marketing surveillance study.

  Pharmacopsychiatry 20090501

• Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study.

  Pharmacopsychiatry 20090501

• A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.

  Behavioural pharmacology 20090501

• Use and safety of antipsychotic drugs during pregnancy.

  Journal of psychiatric practice 20090501

• Treatment options for the patient who does not respond well to initial antidepressant therapy.

  Journal of psychiatric practice 20090501

• Aripiprazole in treatment-refractory schizophrenia.

  Journal of psychiatric practice 20090501

• A review of the safety and tolerability of aripiprazole.

  Expert opinion on drug safety 20090501

• Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.

  The Journal of clinical psychiatry 20090501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090501

• Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.

  Progress in neuro-psychopharmacology & biological psychiatry 20090430

• Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy.

  Progress in neuro-psychopharmacology & biological psychiatry 20090430

• Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.

  The Journal of clinical psychiatry 20090421

• Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism.

  Psychopharmacology 20090401

• Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers.

  Drug and alcohol dependence 20090401

• Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole.

  Therapeutic drug monitoring 20090401

• Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.

  European journal of pharmacology 20090401

• Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.

  Journal of clinical pharmacy and therapeutics 20090401

• How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.

  European psychiatry : the journal of the Association of European Psychiatrists 20090401

• A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia.

  The Journal of clinical psychiatry 20090401

• [Aripiprazole and priapism].

  Atencion primaria 20090401

• Aripiprazole blocks reinstatement but not expression of morphine conditioned place preference in rats.

  Pharmacology, biochemistry, and behavior 20090401

• A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.

  The Journal of clinical psychiatry 20090401

• Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.

  Journal of personality disorders 20090401

• Treatment of delusional parasitosis with aripiprazole.

  Archives of dermatology 20090401

• Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

  CNS spectrums 20090401

• Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.

  Clinical therapeutics 20090401

• Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

  Journal of clinical psychopharmacology 20090401

• Tardive dyskinesia due to aripiprazole: report of 2 cases.

  Journal of clinical psychopharmacology 20090401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090401

• Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy.

  Journal of proteome research 20090401

• Aripiprazole-induced sialorrhea.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• Supersensitivity psychosis after tapering aripiprazole: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.

  Biological psychiatry 20090315

• Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.

  Journal of psychopharmacology (Oxford, England) 20090301

• Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.

  Journal of psychopharmacology (Oxford, England) 20090301

• A case of aripiprazole and tardive dyskinesia.

  Journal of psychopharmacology (Oxford, England) 20090301

• Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.

  Journal of psychiatric research 20090301

• Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder.

  Schizophrenia research 20090301

• A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder.

  Human psychopharmacology 20090301

• The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.

  The Journal of clinical psychiatry 20090301

• Evaluation of Peakmaster for computer-aided multivariate optimisation of a CE separation of 17 antipsychotic drugs using minimal experimental data.

  Electrophoresis 20090301

• Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.

  Journal of psychiatric practice 20090301

• Multiple sclerosis presenting with erotomanic delusions in the context of 'Don't ask, don't tell'.

  Military medicine 20090301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090301

• Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20090301

• Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approaches.

  Psychiatry investigation 20090301

• Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090218

• Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma.

  Analytical biochemistry 20090215

• Refractory restless legs syndrome likely caused by olanzapine.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215

• Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.

  The Journal of clinical psychiatry 20090210

• Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole.

  Annals of emergency medicine 20090201

• Do patients with schizophrenia exhibit aberrant salience?

  Psychological medicine 20090201

• A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic.

  Community mental health journal 20090201

• Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.

  Human molecular genetics 20090201

• A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.

  The American journal of psychiatry 20090201

• Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.

  Schizophrenia research 20090201

• Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.

  Journal of clinical psychopharmacology 20090201

• An open study of aripiprazole and escitalopram for psychotic major depressive disorder.

  Journal of clinical psychopharmacology 20090201

• Aripiprazole in refractory depression?

  Journal of clinical psychopharmacology 20090201

• Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.

  Journal of clinical psychopharmacology 20090201

• Successful switch from clozapine to aripiprazole: a case report.

  Journal of clinical psychopharmacology 20090201

• Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.

  Psychiatry and clinical neurosciences 20090201

• Aripiprazole for psychosis and agitation in Alzheimer's dementia.

  Current psychiatry reports 20090201

• Metabolic risks in older adults receiving second-generation antipsychotic medication.

  Current psychiatry reports 20090201

• Psychosis in the elderly.

  The American journal of psychiatry 20090201

• Prolonged toxicity in a 2-year-old after accidental ingestion of aripiprazole.

  Pediatric emergency care 20090201

• Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol.

  CNS spectrums 20090201

• [A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole].

  L'Encephale 20090201

• Benign clinical picture after ingestion of 780 milligrams of aripiprazole and 1050 milligrams of amitriptyline.

  Indian journal of medical sciences 20090201

• Transport of aripiprazole across Caco-2 monolayer model.

  Yao xue xue bao = Acta pharmaceutica Sinica 20090201

• Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.

  Psychiatry research 20090130

• Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.

  Movement disorders : official journal of the Movement Disorder Society 20090115

• Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.

  Journal of medicinal chemistry 20090108

• Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.

  Lancet (London, England) 20090103

• Combined use of ECT with aripiprazole.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Combined low-dose clozapine with low-dose aripiprazole in a schizophrenic patient.

  Journal of psychopharmacology (Oxford, England) 20090101

• Leukopenia and thrombocytopenia on adding aripiprazole to phenytoin.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors.

  Psychopharmacology 20090101

• A placebo-controlled study of sildenafil effects on cognition in schizophrenia.

  Psychopharmacology 20090101

• Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.

  Journal of affective disorders 20090101

• Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Results of phase 3 of the CATIE schizophrenia trial.

  Schizophrenia research 20090101

• Treatment of alternating hemiplegia of childhood with aripiprazole.

  Developmental medicine and child neurology 20090101

• A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia.

  Journal of the American Medical Directors Association 20090101

• Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.

  The British journal of psychiatry : the journal of mental science 20090101

• Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.

  The American journal of psychiatry 20090101

• Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?

  Current drug safety 20090101

• The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.

  The Journal of clinical psychiatry 20090101

• Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.

  Psychopharmacology bulletin 20090101

• An open-label assessment of aripiprazole in the treatment of PTSD.

  Psychopharmacology bulletin 20090101

• Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study.

  Annals of general psychiatry 20090101

• Aripiprazole-induced agitation after clozapine discontinuation: a case report.

  The Journal of clinical psychiatry 20090101

• A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature.

  Nutrition & metabolism 20090101

• Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study.

  Child and adolescent psychiatry and mental health 20090101

• Central sleep apnea in a geriatric patient treated with aripiprazole.

  American journal of therapeutics 20090101

• Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells.

  BMC pharmacology 20090101

• Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.

  BMC psychiatry 20090101

• No relationship between 2',3'-cyclic nucleotide 3'-phosphodiesterase and schizophrenia in the Chinese Han population: an expression study and meta-analysis.

  BMC medical genetics 20090101

• Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States.

  Cost effectiveness and resource allocation : C/E 20090101

• Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoring.

  Current medicinal chemistry 20090101

• Sertindole versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20090101

• [Paroxysmal perceptual alteration in comparison with hallucination--a review of its clinical reports and discussion of its pathophysiological mechanism in the present day, when second generation antipsychotics are widely used].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20090101

• [Severe and acute hyponatremia in a schizophrenic patient with potomania].

  Anales del sistema sanitario de Navarra 20090101

• Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.

  Trials 20090101

• Schizophrenia pathophysiology: are we any closer to a complete model?

  Annals of general psychiatry 20090101

• Utility of atypical antipsychotics in the treatment of resistant unipolar depression.

  CNS drugs 20090101

• Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

  CNS drugs 20090101

• Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.

  CNS drugs 20090101

• Efficacy and tolerability of aripiprazole in first-episode drug-naive patients with schizophrenia: an open-label trial.

  Clinical neuropharmacology 20090101

• Use of aripiprazole in tardive dyskinesia: an open label study of six cases.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Aripiprazole-induced hiccups: a case report.

  General hospital psychiatry 20090101

• Aripiprazole in the treatment of Huntington's disease: a case series.

  Neuropsychiatric disease and treatment 20090101

• A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole.

  Neuropsychiatric disease and treatment 20090101

• Psychopharmacology of ADHD in pediatrics: current advances and issues.

  Neuropsychiatric disease and treatment 20090101

• Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole.

  Neuropsychiatric disease and treatment 20090101

• Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults.

  BMC medical imaging 20090101

• Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.

  Neuropsychiatric disease and treatment 20090101

• Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia.

  Clinical neuropharmacology 20090101

• Chronic motor tic disorder and aripiprazole.

  The Journal of neuropsychiatry and clinical neurosciences 20090101

• Formulation optimization of long-acting depot injection of aripiprazole by using D-optimal mixture design.

  PDA journal of pharmaceutical science and technology 20090101

• Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.

  Annals of general psychiatry 20090101

• Why do delusions persist?

  Frontiers in human neuroscience 20090101

• The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia.

  Clinical neuropharmacology 20090101

• Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.

  Clinical neuropharmacology 20090101

• Switching of antipsychotics to aripiprazole in the treatment of schizophrenia.

  Chang Gung medical journal 20090101

• Tardive dyskinesia in a patient treated with quetiapine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia.

  Psychosomatics 20090101

• Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.

  General hospital psychiatry 20090101

• Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials.

  Applied health economics and health policy 20090101

• Teratogenicity and hyperprolactinemia.

  Indian journal of psychiatry 20090101

• Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia.

  Clinical interventions in aging 20090101

• A systematic review of augmentation strategies for patients with major depressive disorder.

  Psychopharmacology bulletin 20090101

• Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects.

  BMC psychiatry 20090101

• Improvement in Pisa syndrome and tardive dyskinesia following aripiprazole treatment.

  The Journal of neuropsychiatry and clinical neurosciences 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090101

• [Aripiprazole and acute dystonia].

  Tijdschrift voor psychiatrie 20090101

• Aripiprazole versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20090101

• Ziprasidone versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20090101

• Memantine in the management of a clinically challenging case of bipolar disorder.

  Indian journal of psychiatry 20090101

• Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive-compulsive symptoms and bulimia nervosa: a case report.

  Cases journal 20090101

• Development of Parkinsonism following exposure to aripiprazole: two case reports.

  Journal of medical case reports 20090101

• Schizophrenia-like psychosis following left putamen infarct: a case report.

  Journal of medical case reports 20090101

• Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder.

  Neuropsychiatric disease and treatment 20090101

• Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia.

  Neuropsychiatric disease and treatment 20090101

• Movement disorders associated with aripiprazole use: a case series.

  The International journal of neuroscience 20090101

• Rotarod impairment: catalepsy-like screening test for antipsychotic side effects.

  The International journal of neuroscience 20090101

• Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.

  The Journal of clinical psychiatry 20090101

• Algorithms for the assessment and management of insomnia in primary care.

  Patient preference and adherence 20090101

• Treating bipolar disorder in the primary care setting: the role of aripiprazole.

  Primary care companion to the Journal of clinical psychiatry 20090101

• Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice.

  PloS one 20090101

• Motor function may differentiate attention deficit hyperactivity disorder from early onset bipolar disorder.

  Behavioral and brain functions : BBF 20090101

• Fall-related injuries in a nursing home setting: is polypharmacy a risk factor?

  BMC health services research 20090101

• Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

  Patient preference and adherence 20090101

• Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.

  Annals of general psychiatry 20090101

• Current perspectives in the treatment of resistant schizophrenia.

  Indian journal of psychiatry 20090101

• Severe anorexia nervosa, co-occurring major depressive disorder and electroconvulsive therapy as maintenance treatment: a case report.

  Cases journal 20090101

• Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163).

  Primary care companion to the Journal of clinical psychiatry 20090101

• [Pharmacotherapy in the treatment of borderline personality disorder].

  Rivista di psichiatria 20090101

• Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.

  Indian journal of pharmaceutical sciences 20090101

• Catatonia and CPK elevation in neurosyphilis: role of plural pharmacodynamic mechanisms.

  Psychopharmacology bulletin 20090101

• Behavioral and psychological symptoms of dementia and their management.

  Indian journal of psychiatry 20090101

• Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.

  Indian journal of psychiatry 20090101

• Motor worsening and tardive dyskinesia with aripiprazole in Lewy body dementia.

  BMJ case reports 20090101

• Antipsychotic-induced urinary dysfunction: anticholinergic effect or otherwise?

  BMJ case reports 20090101

• Aripiprazole-induced seizure: a second case report.

  BMJ case reports 20090101

• Olanzapine induced tardive dystonia in case of adolescent bipolar disorder.

  Journal of pediatric neurosciences 20090101

• Cannabis and schizophrenia spectrum disorders: a review of clinical studies.

  Indian journal of psychological medicine 20090101

• Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?

  Behavioural brain research 20081216

• Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer.

  European journal of pharmacology 20081214

• Aripiprazole treatment for depression in schizoaffective disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20081212

• Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20081212

• Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.

  European psychiatry : the journal of the Association of European Psychiatrists 20081201

• Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.

  The international journal of neuropsychopharmacology 20081201

• Neurological adverse events associated with antipsychotic treatment in children and adolescents.

  Journal of child neurology 20081201

• Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081201

• Dopamine D2(High) receptors moderately elevated by bifeprunox and aripiprazole.

  Synapse (New York, N.Y.) 20081201

• [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].

  Fortschritte der Neurologie-Psychiatrie 20081201

• One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia.

  Current medical research and opinion 20081201

• Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.

  Schizophrenia research 20081201

• Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.

  Journal of clinical psychopharmacology 20081201

• Antidepressant-induced sweating alleviated by aripiprazole.

  Journal of clinical psychopharmacology 20081201

• Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.

  The Journal of clinical psychiatry 20081201

• Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.

  British journal of clinical pharmacology 20081201

• Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.

  Expert opinion on pharmacotherapy 20081201

• Market watch : Pharma industry strategic performance: 2007-2012E.

  Nature reviews. Drug discovery 20081201

• An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy.

  Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 20081201

• Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).

  Experimental and clinical psychopharmacology 20081201

• Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20081201

• Incomplete response in late-life depression: getting to remission.

  Dialogues in clinical neuroscience 20081201

• Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.

  The Journal of clinical psychiatry 20081201

• A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.

  The Journal of clinical psychiatry 20081201

• Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.

  Neuropsychiatric disease and treatment 20081201

• Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.

  Psychiatry research 20081130

• Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.

  European journal of pharmacology 20081112

• Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.

  European journal of pharmacology 20081112

• Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.

  Schizophrenia bulletin 20081101

• Use of Aripiprazole in treatment resistant schizophrenia.

  Journal of psychopharmacology (Oxford, England) 20081101

• Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats.

  Psychopharmacology 20081101

• Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.

  Diabetes & metabolism 20081101

• Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia.

  Synapse (New York, N.Y.) 20081101

• Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.

  The international journal of neuropsychopharmacology 20081101

• A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.

  The American journal of psychiatry 20081101

• Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.

  Alcoholism, clinical and experimental research 20081101

• Short-term physical compatibility of intramuscular aripiprazole with intramuscular lorazepam.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081101

• Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK .

  Current medical research and opinion 20081101

• Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder.

  Evidence-based mental health 20081101

• Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.

  The American journal of psychiatry 20081101

• Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test.

  Journal of pharmacological sciences 20081101

• Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.

  Journal of psychiatric practice 20081101

• Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.

  The American journal of psychiatry 20081001

• Amphetamine as a risk factor for aripiprazole-induced acute dystonia.

  Progress in neuro-psychopharmacology & biological psychiatry 20081001

• Catatonia resolution and aripiprazole.

  The Australian and New Zealand journal of psychiatry 20081001

• The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials.

  Schizophrenia research 20081001

• A clinical paradigm of delusions of parasitosis.

  Journal of the American Academy of Dermatology 20081001

• A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.

  Journal of clinical psychopharmacology 20081001

• Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder?

  Journal of clinical psychopharmacology 20081001

• An open-label study of aripiprazole in nonschizophrenic crack-dependent patients.

  Journal of clinical psychopharmacology 20081001

• Bipolar drug development: are we getting closer to the real world?

  The American journal of psychiatry 20081001

• Changing trends in pediatric antipsychotic use in Florida's Medicaid program.

  Psychiatric services (Washington, D.C.) 20081001

• Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.

  Psychiatric services (Washington, D.C.) 20081001

• Current evidence for aripiprazole as augmentation therapy in major depressive disorder.

  Expert review of neurotherapeutics 20081001

• Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.

  Journal of child and adolescent psychopharmacology 20081001

• Psychosis or atypical neuroleptic malignant syndrome in an adolescent?

  Journal of child and adolescent psychopharmacology 20081001

• Unusual weight fluctuation under corticosteroid and psychotropic treatment.

  Psychiatry and clinical neurosciences 20081001

• Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.

  Psychiatry and clinical neurosciences 20081001

• Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.

  The American journal of geriatric pharmacotherapy 20081001

• Augmentation treatment in major depressive disorder: focus on aripiprazole.

  Neuropsychiatric disease and treatment 20081001

• An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia.

  Neuropsychiatric disease and treatment 20081001

• The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.

  European journal of pharmacology 20080911

• Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.

  European journal of pharmacology 20080911

• [The neuroleptic treatment of delusional parasitosis: first experiences with aripiprazole].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20080901

• The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.

  The international journal of neuropsychopharmacology 20080901

• A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.

  Journal of affective disorders 20080901

• Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy.

  Journal of psychopharmacology (Oxford, England) 20080901

• Delusional disorder, somatic type treated with aripiprazole--mirtazapine combination.

  Journal of psychopharmacology (Oxford, England) 20080901

• The safety of the electroconvulsive therapy-aripiprazole combination: four case reports.

  The journal of ECT 20080901

• Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.

  The Annals of pharmacotherapy 20080901

• Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.

  Behavioural pharmacology 20080901

• Combination of aripiprazole and other psychopharmacological treatments in resistant and multi-resistant patients.

  Current drug safety 20080901

• A 12-month follow-up study of treating overweight schizophrenic patients with aripiprazole.

  Acta psychiatrica Scandinavica 20080901

• Practical guidance for prescribing with aripiprazole in bipolar disorder.

  Current medical research and opinion 20080901

• Diabetic ketoacidosis associated with aripiprazole.

  Pharmacotherapy 20080901

• Aripiprazole in the treatment of primary delusional parasitosis.

  The British journal of psychiatry : the journal of mental science 20080901

• Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease.

  The American journal of psychiatry 20080901

• Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.

  Psychiatria Danubina 20080901

• [The use of antipsychotics in patients with dementia].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20080901

• Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole.

  Clinical interventions in aging 20080901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080901

• Predictors of aripiprazole treatment continuation in hospitalized patients.

  The Journal of clinical psychiatry 20080901

• Dextromethorphan-induced serotonin syndrome.

  Clinical toxicology (Philadelphia, Pa.) 20080901

• Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors.

  Behavioural brain research 20080805

• Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patient.

  Schizophrenia research 20080801

• Controversies in translational research: drug self-administration.

  Psychopharmacology 20080801

• Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.

  The American journal of psychiatry 20080801

• Combined antipsychotic treatment involving clozapine and aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20080801

• Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study.

  European psychiatry : the journal of the Association of European Psychiatrists 20080801

• Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia.

  Human molecular genetics 20080801

• Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.

  Journal of clinical psychopharmacology 20080801

• Aripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20080801

• Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series.

  Journal of clinical psychopharmacology 20080801

• Case report of aripiprazole for persistent developmental stuttering.

  Journal of clinical psychopharmacology 20080801

• Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia.

  Therapeutic drug monitoring 20080801

• New insights into clinical response in schizophrenia: from dopamine D2 receptor occupancy to patients' quality of life.

  The American journal of psychiatry 20080801

• Aripiprazole in children with attention-deficit/hyperactivity disorder.

  Journal of child and adolescent psychopharmacology 20080801

• Adjunctive aripiprazole decreased metabolic side effects of clozapine treatment.

  Neuro endocrinology letters 20080801

• Aripiprazole-induced orthostatic hypotension and cardiac arrhythmia.

  Psychiatry and clinical neurosciences 20080801

• Current approaches to the treatment of Parkinson's disease.

  Neuropsychiatric disease and treatment 20080801

• Aripiprazole versus typical antipsychotic drugs for schizophrenia.

  The Cochrane database of systematic reviews 20080716

• Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.

  European journal of pharmacology 20080707

• Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.

  Progress in neuro-psychopharmacology & biological psychiatry 20080701

• Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.

  Journal of psychopharmacology (Oxford, England) 20080701

• The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.

  Basic & clinical pharmacology & toxicology 20080701

• Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.

  Journal of neurochemistry 20080701

• Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms.

  Progress in neuro-psychopharmacology & biological psychiatry 20080701

• Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.

  Psychopharmacology 20080701

• Adjunctive aripiprazole for bupropion-resistant major depression.

  The Annals of pharmacotherapy 20080701

• Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.

  Acta psychiatrica Scandinavica 20080701

• Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function.

  Psychopharmacology 20080701

• Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.

  The Journal of clinical psychiatry 20080701

• Case report of aripiprazole usage during pregnancy.

  Archives of women's mental health 20080701

• A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20080701

• Significance of findings in aripiprazole for treatment of psychoses in Alzheimer dementia.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20080701

• A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.

  The Journal of clinical psychiatry 20080701

• D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole.

  Drug development and industrial pharmacy 20080701

• Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosis.

  Pharmacopsychiatry 20080701

• Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.

  Drug metabolism and disposition: the biological fate of chemicals 20080601

• Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization.

  Journal of neural transmission (Vienna, Austria : 1996) 20080601

• Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.

  Psychoneuroendocrinology 20080601

• Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.

  Neuropharmacology 20080601

• Antipsychotic drug action: antagonism, inverse agonism or partial agonism.

  Trends in pharmacological sciences 20080601

• Proposed strategies for successful clinical management with aripiprazole.

  Expert opinion on pharmacotherapy 20080601

• Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.

  Journal of clinical psychopharmacology 20080601

• Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms.

  Journal of clinical psychopharmacology 20080601

• Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.

  Journal of clinical psychopharmacology 20080601

• Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats.

  Metabolic brain disease 20080601

• Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy.

  Diabetes care 20080601

• First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis.

  The British journal of psychiatry : the journal of mental science 20080601

• Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions.

  Current drug metabolism 20080601

• Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.

  CNS spectrums 20080601

• Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder.

  CNS spectrums 20080601

• Successful treatment of delusional disorder with low-dose aripiprazole.

  Psychiatry and clinical neurosciences 20080601

• [Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20080601

• Apparent commercial bias in supplement.

  The Journal of clinical psychiatry 20080601

• Is aripiprazole an efficacious adjunct for unipolar depression?

  The Journal of clinical psychiatry 20080601

• Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

  Clinical interventions in aging 20080601

• Acute and long-term treatment of mania.

  Dialogues in clinical neuroscience 20080601

• Bipolar depression: trial-based insights to guide patient care.

  Dialogues in clinical neuroscience 20080601

• Current research in child and adolescent bipolar disorder.

  Dialogues in clinical neuroscience 20080601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080601

• Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial.

  Neuropsychiatric disease and treatment 20080601

• Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD).

  Current neuropharmacology 20080601

• Cognitive factors for predicting treatment response in schizophrenic patients: one-year follow-up study.

  Psychiatry investigation 20080601

• Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080501

• Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells.

  The international journal of neuropsychopharmacology 20080501

• New treatments for cocaine dependence: a focused review.

  The international journal of neuropsychopharmacology 20080501

• Dysfunction in configural face processing in patients with schizophrenia.

  Schizophrenia bulletin 20080501

• Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome.

  The international journal of neuropsychopharmacology 20080501

• Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.

  Journal of psychopharmacology (Oxford, England) 20080501

• Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.

  Psychopharmacology 20080501

• Change in sexual dysfunction with aripiprazole: a switching or add-on study.

  Journal of psychopharmacology (Oxford, England) 20080501

• Prolactin awareness: an essential consideration for physical health in schizophrenia.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080501

• Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080501

• Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.

  The Journal of clinical psychiatry 20080501

• Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study.

  International journal of clinical practice 20080501

• Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care.

  The Journal of clinical psychiatry 20080501

• Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements.

  Psychiatric services (Washington, D.C.) 20080501

• Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.

  Psychiatric services (Washington, D.C.) 20080501

• Aripiprazole joins the family of second-generation mood stabilizers.

  The Journal of clinical psychiatry 20080501

• Intrinsic activity of aripiprazole is not 30% of dopamine, but only about 6% under ideal antipsychotic therapy.

  The Journal of clinical psychiatry 20080501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080501

• Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder.

  Psychiatry (Edgmont (Pa. : Township)) 20080501

• Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection.

  Analytica chimica acta 20080407

• Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.

  Journal of affective disorders 20080401

• Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient.

  Progress in neuro-psychopharmacology & biological psychiatry 20080401

• [Current pharmacotherapies and immunotherapy in cocaine addiction].

  Presse medicale (Paris, France : 1983) 20080401

• Aripiprazole as an adjunctive treatment for refractory unipolar depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20080401

• Aripiprazole treatment for risperidone-associated tic movement: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20080401

• Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.

  Acta psychiatrica Scandinavica 20080401

• Effects of aripiprazole on subjective and physiological responses to alcohol.

  Alcoholism, clinical and experimental research 20080401

• Partial agonists and suicide: the role of the mental health nurse.

  Journal of psychiatric and mental health nursing 20080401

• Sexual dysfunction in schizophrenia: focus on recent evidence.

  Human psychopharmacology 20080401

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

  Journal of clinical psychopharmacology 20080401

• Photo-onycholysis caused by olanzapine and aripiprazole.

  Journal of clinical psychopharmacology 20080401

• Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.

  Journal of clinical psychopharmacology 20080401

• Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man.

  Journal of clinical psychopharmacology 20080401

• Delayed presentation of an aripiprazole overdose.

  Clinical toxicology (Philadelphia, Pa.) 20080401

• Effect of aripiprazole on 5-HT2 receptor-mediated wet-dog shake responses and disruption of prepulse inhibition in rats.

  Journal of pharmacological sciences 20080401

• Do dopamine partial agonists have partial efficacy as antipsychotics?

  CNS spectrums 20080401

• Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.

  Journal of child and adolescent psychopharmacology 20080401

• The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study.

  Clinical therapeutics 20080401

• [Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].

  L'Encephale 20080401

• [Atypical antipsychotics in first-episode psychosis: a review].

  L'Encephale 20080401

• Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats.

  Neuropsychiatric disease and treatment 20080401

• Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex.

  The international journal of neuropsychopharmacology 20080301

• [Recurrent dysregulation of body temperature during antipsychotic pharmacotherapy].

  Psychiatrische Praxis 20080301

• Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004.

  Current medical research and opinion 20080301

• Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects.

  The American journal of psychiatry 20080301

• Aripiprazole's receptor pharmacology and extrapyramidal side effects.

  The American journal of psychiatry 20080301

• Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice.

  Behavioural pharmacology 20080301

• Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.

  The Journal of clinical psychiatry 20080301

• The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice.

  Alcohol (Fayetteville, N.Y.) 20080301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080301

• Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.

  European journal of pharmacology 20080226

• Effectiveness of aripiprazole in treating obsessive compulsive symptoms.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Tardive dystonic symptoms associated with aripiprazole treatment.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Aripiprazole: a treatment for severe coprolalia in 'refractory' Gilles de la Tourette syndrome.

  Movement disorders : official journal of the Movement Disorder Society 20080215

• Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain.

  Journal of neuroscience research 20080201

• Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats.

  Neuropharmacology 20080201

• Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers.

  Pharmacogenetics and genomics 20080201

• A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.

  Journal of clinical psychopharmacology 20080201

• Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.

  Journal of clinical psychopharmacology 20080201

• A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.

  The Journal of clinical psychiatry 20080201

• Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone.

  Evidence-based mental health 20080201

• Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

  European journal of clinical pharmacology 20080201

• Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.

  The Journal of clinical psychiatry 20080201

• Quetiapine monotherapy for bipolar depression.

  Neuropsychiatric disease and treatment 20080201

• Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder.

  Neuropsychiatric disease and treatment 20080201

• Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia.

  Neuropsychiatric disease and treatment 20080201

• Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.

  Behavioural brain research 20080125

• Aripiprazole versus typicals for schizophrenia.

  The Cochrane database of systematic reviews 20080123

• Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.

  European journal of pharmacology 20080114

• [Aripiprazole for the treatment of Tourette's syndrome].

  Ugeskrift for laeger 20080107

• Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.

  Depression and anxiety 20080101

• Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.

  Schizophrenia research 20080101

• Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

  Molecular psychiatry 20080101

• Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20080101

• Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia.

  Schizophrenia bulletin 20080101

• Reversal of trichotillomania with aripiprazole.

  Depression and anxiety 20080101

• Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats.

  Journal of neural transmission (Vienna, Austria : 1996) 20080101

• The effect of aripiprazole on prepulse inhibition of the startle response in normal and hyperdopaminergic states in rats.

  The International journal of neuroscience 20080101

• Buspirone for autistic disorder in a woman with an intellectual disability.

  The Annals of pharmacotherapy 20080101

• Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.

  Nuclear medicine and biology 20080101

• Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis.

  Brain injury 20080101

• Electroconvulsive therapy in the treatment of mixed states in bipolar disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20080101

• Olfactory reference syndrome.

  Psychosomatics 20080101

• Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.

  Journal of psychiatric practice 20080101

• Antipsychotic drugs alter neuronal development including ALM neuroblast migration and PLM axonal outgrowth in Caenorhabditis elegans.

  International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20080101

• Recognizing thyrotoxicosis in a patient with bipolar mania: a case report.

  Annals of general psychiatry 20080101

• Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

• Aripiprazole diminishes cannabis use in schizophrenia.

  The Journal of neuropsychiatry and clinical neurosciences 20080101

• Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial.

  The Journal of clinical psychiatry 20080101

• Incorporating clinical guidelines through clinician decision-making.

  Implementation science : IS 20080101

• Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder.

  CNS drugs 20080101

• The use of atypical antipsychotics after traumatic brain injury.

  The Journal of head trauma rehabilitation 20080101

• Antipsychotic-induced oxidative stress in rat brain.

  Neurotoxicity research 20080101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080101

• Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

  BMC psychiatry 20080101

• Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.

  CNS drugs 20080101

• Effectiveness of second generation antipsychotics: a systematic review of randomized trials.

  BMC psychiatry 20080101

• Clozapine and co-prescribed psychotropics: a short report.

  Clinical practice and epidemiology in mental health : CP & EMH 20080101

• Aripiprazole in prodromal psychosis: a case report.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Incentive motivation in first-episode psychosis: a behavioural study.

  BMC psychiatry 20080101

• [Advances in the treatment of mania: aripiprazole].

  Actas espanolas de psiquiatria 20080101

• Diabetic control and atypical antipsychotics: a case report.

  Journal of medical case reports 20080101

• Pharmacological management of atypical antipsychotic-induced weight gain.

  CNS drugs 20080101

• Aripiprazole in adolescents with schizophrenia: profile report.

  CNS drugs 20080101

• [Present data and treatment schedule of aripiprazole in the treatment of schizophrenia].

  L'Encephale 20080101

• Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.

  Clinical neuropharmacology 20080101

• The use of atypical antipsychotics in pediatric bipolar disorder.

  The Journal of clinical psychiatry 20080101

• Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.

  The Journal of clinical psychiatry 20080101

• Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

  The Journal of clinical psychiatry 20080101

• Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders.

  The Journal of clinical psychiatry 20080101

• Decrease in tobacco consumption after treatment with topiramate and aripiprazole: a case report.

  Journal of medical case reports 20080101

• [Reaction to 'Augmentation with atypical antipsychotics in the treatment of patients with a therapy-resistant depression: a review'].

  Tijdschrift voor psychiatrie 20080101

• Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia.

  Clinical pharmacokinetics 20080101

• Worsening of psychosis in a 30 year old man with undifferentiated schizophrenia.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

• Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation.

  Parkinsonism & related disorders 20080101

• Commentary on strategies for switching antipsychotics.

  BMC medicine 20080101

• Neurobiology confirms psychopathology. On the antagonism of psychosis and obsessive-compulsive syndromes.

  Psychopathology 20080101

• Delirium and its treatment.

  CNS drugs 20080101

• Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole.

  Clinical pharmacokinetics 20080101

• Small doses of aripiprazole augmentation of antidepressant treatment: a report of 3 cases.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

  Drugs & aging 20080101

• Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010).

  Psychopharmacology bulletin 20080101

• [Brain in the core of metabolic regulations: disorders in schizophrenic patients treated with atypical antipsychotics].

  Revue medicale de Liege 20080101

• [Emergent mania with atypical antipsychotics: review of the literature about one case].

  Therapie 20080101

• The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation.

  Child and adolescent psychiatry and mental health 20080101

• Costs of treating patients with schizophrenia who have illness-related crisis events.

  BMC psychiatry 20080101

• Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study.

  Annals of general psychiatry 20080101

• Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.

  Progress in brain research 20080101

• Aripiprazole-induced acneiform eruption.

  General hospital psychiatry 20080101

• Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use.

  PloS one 20080101

• Coverage of atypical antipsychotics among medicare drug plans in the state of washington for fiscal year 2007.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Aripiprazole: in major depressive disorder.

  CNS drugs 20080101

• Antipsychotic-induced hyponatremia: case report and literature review.

  American journal of therapeutics 20080101

• Clinical trials with a new atypical antipsychotic (Aripiprazole): gender specific information analysis.

  Women & health 20080101

• The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period.

  The American journal of drug and alcohol abuse 20080101

• Effective treatment of premenstrual violence in major depression: augmentation with aripiprazole.

  Chang Gung medical journal 20080101

• Cognitive-enhancing effects of aripiprazole: a case report.

  Clinical practice and epidemiology in mental health : CP & EMH 20080101

• Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation.

  Health and quality of life outcomes 20080101

• Pharmacotherapy of methamphetamine addiction: an update.

  Substance abuse 20080101

• Treatment-resistant depression: recent developments and future directions.

  Depression and anxiety 20080101

• The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).

  BMC psychiatry 20080101

• Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report.

  Annals of general psychiatry 20080101

• Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.

  The Journal of clinical psychiatry 20080101

• Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Aripiprazole in schizotypal personality disorder: a case report.

  Primary care companion to the Journal of clinical psychiatry 20080101

• A case of pancreatitis associated with aripiprazole in the absence of hyperglycemia.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Aripiprazole (abilify) and tardive dyskinesia.

  P & T : a peer-reviewed journal for formulary management 20080101

• Hyperprolactinaemia with amisulpride.

  Indian journal of psychiatry 20080101

• Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia.

  Patient preference and adherence 20080101

• A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.

  Journal of psychiatric research 20071201

• Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA/2NCrl mice.

  Psychopharmacology 20071201

• Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole.

  European journal of clinical pharmacology 20071201

• A prospective 6-month analysis of the naturalistic use of aripiprazole - factors predicting favourable outcome.

  Acta psychiatrica Scandinavica 20071201

• Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia.

  International journal of clinical practice 20071201

• Ghrelin and leptin response to oral glucose challenge among antipsychotic drug-treated children.

  Journal of clinical psychopharmacology 20071201

• Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.

  Journal of clinical psychopharmacology 20071201

• Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.

  Journal of clinical psychopharmacology 20071201

• Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent.

  Journal of clinical psychopharmacology 20071201

• Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study.

  The British journal of psychiatry. Supplement 20071201

• Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety.

  The Journal of clinical psychiatry 20071201

• Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.

  The Journal of clinical psychiatry 20071201

• Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.

  Clinical toxicology (Philadelphia, Pa.) 20071201

• Aripiprazole: effectiveness and safety under naturalistic conditions.

  Experimental and clinical psychopharmacology 20071201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071201

• Management of the behavioral and psychological symptoms of dementia.

  Clinical interventions in aging 20071201

• Ziprasidone in the treatment of mania in bipolar disorder.

  Neuropsychiatric disease and treatment 20071201

• Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review.

  Neuropsychiatric disease and treatment 20071201

• Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies.

  Neuropsychiatric disease and treatment 20071201

• A review of quetiapine in combination with antidepressant therapy in patients with depression.

  Neuropsychiatric disease and treatment 20071201

• Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians.

  Neuropsychiatric disease and treatment 20071201

• Current therapeutic options for Alzheimer's disease.

  Current genomics 20071201

• Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action.

  Neuroscience 20071130

• Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.

  European journal of pharmacology 20071128

• Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone.

  Schizophrenia bulletin 20071101

• Possible psychotropic effects of Aripiprazole.

  Schizophrenia research 20071101

• Effect of antipsychotics on creatine kinase activity in rat brain.

  Basic & clinical pharmacology & toxicology 20071101

• Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.

  International clinical psychopharmacology 20071101

• Augmentation of aripiprazole with low-dose clozapine.

  Pharmacotherapy 20071101

• Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20071101

• Psychotic episode associated with Bikram yoga.

  The American journal of psychiatry 20071101

• Nonlinear mixed effects model analysis of the pharmacokinetics of aripiprazole in healthy Japanese males.

  Biological & pharmaceutical bulletin 20071101

• Treatment of bipolar disorder: the evolving role of atypical antipsychotics.

  The American journal of managed care 20071101

• Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.

  The Journal of clinical psychiatry 20071101

• Aripiprazole and perphenazine: no difference.

  The Journal of clinical psychiatry 20071101

• A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.

  The Journal of clinical psychiatry 20071101

• Aripiprazole treatment of patients with borderline personality disorder.

  The Journal of clinical psychiatry 20071101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071101

• Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.

  European journal of pharmacology 20071031

• Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.

  Journal of medicinal chemistry 20071018

• Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071001

• An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.

  International journal of geriatric psychiatry 20071001

• Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

  Molecular psychiatry 20071001

• A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

  European psychiatry : the journal of the Association of European Psychiatrists 20071001

• Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.

  Pharmacology, biochemistry, and behavior 20071001

• Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain.

  Naunyn-Schmiedeberg's archives of pharmacology 20071001

• Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.

  Current medical research and opinion 20071001

• A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).

  Current medical research and opinion 20071001

• Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.

  Bioorganic & medicinal chemistry letters 20071001

• Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.

  Naunyn-Schmiedeberg's archives of pharmacology 20071001

• Adjunctive aripiprazole in combat-related posttraumatic stress disorder.

  The Annals of pharmacotherapy 20071001

• Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.

  Journal of clinical psychopharmacology 20071001

• Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study.

  Journal of clinical psychopharmacology 20071001

• Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.

  Journal of clinical psychopharmacology 20071001

• Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.

  Journal of clinical psychopharmacology 20071001

• Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

  The American journal of psychiatry 20071001

• Aripiprazole: malignant syndrome.

  Prescrire international 20071001

• Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial.

  CNS spectrums 20071001

• Managing the acutely agitated and psychotic patient.

  CNS spectrums 20071001

• Practical strategies for assessing and stabilizing bipolar patients in urgent situations.

  The Journal of clinical psychiatry 20071001

• Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.

  The Journal of clinical psychiatry 20071001

• Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.

  The Journal of clinical psychiatry 20071001

• A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole.

  The Journal of clinical psychiatry 20071001

• Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism.

  Drug metabolism and pharmacokinetics 20071001

• Successful treatment of catatonia with aripiprazole in an adolescent with psychosis.

  Journal of child and adolescent psychopharmacology 20071001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071001

• Pharmacological causes of hyperprolactinemia.

  Therapeutics and clinical risk management 20071001

• Review of olanzapine in the management of bipolar disorders.

  Neuropsychiatric disease and treatment 20071001

• Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis.

  European journal of pharmacology 20070910

• Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901

• Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks.

  Schizophrenia research 20070901

• Agitation associated with aripiprazole initiation.

  Pharmacotherapy 20070901

• Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?

  The American journal of psychiatry 20070901

• Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

  The American journal of psychiatry 20070901

• Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.

  The American journal of psychiatry 20070901

• Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.

  The American journal of psychiatry 20070901

• Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.

  The American journal of psychiatry 20070901

• An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.

  CNS spectrums 20070901

• Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.

  Bipolar disorders 20070901

• Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.

  The Journal of clinical psychiatry 20070901

• Aripiprazole-induced psychosis: a case report of reexposure by stepwise up-titration.

  The Journal of clinical psychiatry 20070901

• Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure.

  Eating and weight disorders : EWD 20070901

• Olanzapine and acute urinary retention in two geriatric patients.

  The American journal of geriatric pharmacotherapy 20070901

• In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.

  Journal of psychopharmacology (Oxford, England) 20070801

• Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.

  Journal of psychopharmacology (Oxford, England) 20070801

• Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.

  Journal of affective disorders 20070801

• Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.

  Journal of neurochemistry 20070801

• Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications.

  Human psychopharmacology 20070801

• Action of novel antipsychotics at human dopamine D3 receptors coupled to G protein and ERK1/2 activation.

  Neuropharmacology 20070801

• Metabolic side effects of antipsychotic medication.

  International journal of clinical practice 20070801

• GPCR functional selectivity has therapeutic impact.

  Trends in pharmacological sciences 20070801

• Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.

  Journal of clinical psychopharmacology 20070801

• Acute pancreatitis and diabetic ketoacidosis in a schizophrenic patient taking olanzapine.

  Journal of clinical psychopharmacology 20070801

• Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia.

  Evidence-based mental health 20070801

• Maintenance treatment in bipolar disorder: a focus on aripiprazole.

  Expert review of neurotherapeutics 20070801

• Metabolic effects of the atypical antipsychotics.

  Southern medical journal 20070801

• The role of lamotrigine in the management of bipolar disorder.

  Neuropsychiatric disease and treatment 20070801

• Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070701

• Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.

  Psychopharmacology 20070701

• Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.

  Neurochemical research 20070701

• Concomitant use of lamotrigine and aripiprazole increases risk of Stevens-Johnson syndrome?

  International clinical psychopharmacology 20070701

• Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel.

  Current medical research and opinion 20070701

• Aripiprazole--data on efficacy and associated mortality.

  The British journal of psychiatry : the journal of mental science 20070701

• Aripiprazole--data on efficacy and associated mortality.

  The British journal of psychiatry : the journal of mental science 20070701

• Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.

  Current opinion in investigational drugs (London, England : 2000) 20070701

• An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.

  The Journal of clinical psychiatry 20070701

• EEG Abnormalities in a patient taking Aripiprazole.

  Psychiatry (Edgmont (Pa. : Township)) 20070701

• Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?

  Journal of psychopharmacology (Oxford, England) 20070601

• Aripiprazole in human milk.

  The international journal of neuropsychopharmacology 20070601

• Abnormal glucose metabolism in patients treated with antipsychotics.

  Diabetes & metabolism 20070601

• Aripiprazole acts as a selective dopamine D2 receptor partial agonist.

  Expert opinion on investigational drugs 20070601

• Pharmacokinetics of aripiprazole and concomitant carbamazepine.

  Journal of clinical psychopharmacology 20070601

• Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months.

  Journal of clinical psychopharmacology 20070601

• Aripiprazole-induced obsessive-compulsive disorder: a report of 2 cases.

  Journal of clinical psychopharmacology 20070601

• Aripiprazole for treatment of behavioural psychological symptoms of dementia.

  The Australian and New Zealand journal of psychiatry 20070601

• New developments in the pharmacotherapy of cocaine abuse.

  Addiction biology 20070601

• Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070601

• Relief from migraine headache with aripiprazole treatment.

  Headache 20070601

• Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.

  The Journal of clinical psychiatry 20070601

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

  The Journal of clinical psychiatry 20070601

• Schizophrenia symptoms remain stable during decreases from 2 antipsychotics to aripiprazole.

  The Journal of clinical psychiatry 20070601

• Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20070601

• Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.

  Dialogues in clinical neuroscience 20070601

• Quality of life in schizophrenic patients.

  Dialogues in clinical neuroscience 20070601

• [Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients].

  Revista medica de Chile 20070601

• A case series: evaluation of the metabolic safety of aripiprazole.

  Schizophrenia bulletin 20070501

• Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up.

  Psychopharmacology 20070501

• A clinical study of the association of antipsychotics with hyperlipidemia.

  Schizophrenia research 20070501

• Aripiprazole: pharmacology and evidence in bipolar disorder.

  Expert opinion on pharmacotherapy 20070501

• Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials.

  The Journal of clinical psychiatry 20070501

• Augmentation of clozapine treatment with aripiprazole.

  The Journal of clinical psychiatry 20070501

• Aripiprazole and worsening of psychosis: a case report.

  The Journal of clinical psychiatry 20070501

• Violent behavior.

  Journal of psychiatric practice 20070501

• Intramuscular aripiprazole in the control of agitation.

  Journal of psychiatric practice 20070501

• Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.

  Journal of psychiatric practice 20070501

• Effects of comedication on the serum levels of aripiprazole: evidence from a routine therapeutic drug monitoring service.

  Pharmacopsychiatry 20070501

• [Spectroscopic studies of aripiprazole].

  Guang pu xue yu guang pu fen xi = Guang pu 20070501

• Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070415

• Psychosis in a patient with Fabry's disease and treatment with aripiprazole.

  Progress in neuro-psychopharmacology & biological psychiatry 20070413

• Aripiprazole in delusional parasitosis: Case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20070413

• Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.

  Psychopharmacology 20070401

• Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.

  Psychopharmacology 20070401

• The effect of atypical versus typical antipsychotics on tardive dyskinesia: a naturalistic study.

  European archives of psychiatry and clinical neuroscience 20070401

• Unique pharmacological profile of aripiprazole as the phasic component buster.

  Psychopharmacology 20070401

• The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice.

  Psychopharmacology 20070401

• In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.

  Psychopharmacology 20070401

• Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.

  Journal of clinical pharmacy and therapeutics 20070401

• Use of atypical antipsychotics in the treatment of autistic disorder.

  The Annals of pharmacotherapy 20070401

• Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials.

  Archives of general psychiatry 20070401

• An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.

  Journal of clinical psychopharmacology 20070401

• Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.

  Journal of clinical psychopharmacology 20070401

• Aripiprazole and neuroleptic malignant syndrome.

  Journal of clinical psychopharmacology 20070401

• Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.

  Journal of clinical psychopharmacology 20070401

• Worsening of obsessive-compulsive symptoms after treatment with aripiprazole.

  Journal of clinical psychopharmacology 20070401

• Aripiprazole-induced hyponatremia: a case report.

  The Journal of clinical psychiatry 20070401

• [Clinical observation on effect of Jieyu Anshen Decoction combined with aripiprazole in treating chronic schizophrenia].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070401

• Quetiapine in the treatment of schizophrenia and related disorders.

  Neuropsychiatric disease and treatment 20070401

• An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration.

  Neuropsychiatric disease and treatment 20070401

• Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.

  Progress in neuro-psychopharmacology & biological psychiatry 20070330

• Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.

  Progress in neuro-psychopharmacology & biological psychiatry 20070330

• Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.

  Progress in neuro-psychopharmacology & biological psychiatry 20070330

• Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.

  Biological psychiatry 20070301

• Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition.

  The Journal of pharmacology and experimental therapeutics 20070301

• Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels.

  Neuropharmacology 20070301

• Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation.

  International clinical psychopharmacology 20070301

• Acute dystonia associated with aripiprazole in a child.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070301

• Management of agitation in the acute psychotic patient--efficacy without excessive sedation.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070301

• The stable patient with schizophrenia--from antipsychotic effectiveness to adherence.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070301

• The long term--maximising potential for rehabilitation in patients with schizophrenia.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070301

• Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review.

  The Journal of clinical psychiatry 20070301

• Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis.

  Journal of psychiatric practice 20070301

• Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.

  Journal of psychiatric practice 20070301

• Aripiprazole worsening positive symptoms and memantine reducing negative symptoms in a patient with paranoid schizophrenia.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20070301

• Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient.

  Pharmacopsychiatry 20070301

• Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.

  The Australian and New Zealand journal of psychiatry 20070301

• Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.

  Journal of medicinal chemistry 20070208

• Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.

  The international journal of neuropsychopharmacology 20070201

• [Psychotropic drug-induced change of weight: a review].

  Fortschritte der Neurologie-Psychiatrie 20070201

• Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.

  The international journal of neuropsychopharmacology 20070201

• Habituation deficits induced by metabotropic glutamate receptors 2/3 receptor blockade in mice: reversal by antipsychotic drugs.

  The Journal of pharmacology and experimental therapeutics 20070201

• Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.

  Psychopharmacology 20070201

• Lamotrigine-induced Stevens-Johnson syndrome.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070201

• Continuing aripiprazole after stabilisation of a manic or mixed episode of bipolar I disorder delays relapse.

  Evidence-based mental health 20070201

• Review: aripiprazole for schizophrenia--more high quality research required.

  Evidence-based mental health 20070201

• Schizophrenia: multi-attribute utility theory approach to selection of atypical antipsychotics.

  The Annals of pharmacotherapy 20070201

• Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.

  The Journal of clinical psychiatry 20070201

• Indexing of reports on aripiprazole augmentation of clozapine.

  The Journal of clinical psychiatry 20070201

• Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic.

  Neuropsychiatric disease and treatment 20070201

• Aripiprazole treatment of Asperger's syndrome in the acute psychiatric setting: case report.

  Neuropsychiatric disease and treatment 20070201

• Pisa syndrome during aripiprazole treatment: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20070130

• Leukopenia and neutropenia induced by quetiapine.

  Progress in neuro-psychopharmacology & biological psychiatry 20070130

• Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101

• Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

  Schizophrenia research 20070101

• The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment.

  Psychopharmacology 20070101

• Aripiprazole augmentation for treatment of patients with inadequate antidepressants response.

  Depression and anxiety 20070101

• Atypical antipsychotics in the treatment of mood disorders.

  Current opinion in psychiatry 20070101

• Aripiprazole in the treatment of schizophrenia: a consensus report produced by schizophrenia experts in Italy.

  Clinical drug investigation 20070101

• Adjunctive aripiprazole in bipolar I depression.

  The Annals of pharmacotherapy 20070101

• Cmap ADHD and comorbid aggression algorithm.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070101

• A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.

  The American journal of psychiatry 20070101

• Manic episode during treatment with aripiprazole.

  The American journal of psychiatry 20070101

• Hyperglycemia in a 7-year-old child treated with aripiprazole.

  The American journal of psychiatry 20070101

• Safety of aripiprazole: high serum levels in a CYP2D6 mutated patient.

  The American journal of psychiatry 20070101

• Metabolic drug interactions with newer antipsychotics: a comparative review.

  Basic & clinical pharmacology & toxicology 20070101

• Datapoints: The ups and downs of dosing second-generation antipsychotics.

  Psychiatric services (Washington, D.C.) 20070101

• Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.

  Current medical research and opinion 20070101

• Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient.

  Clinical neuropharmacology 20070101

• Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial.

  The Journal of clinical psychiatry 20070101

• Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.

  The Journal of clinical psychiatry 20070101

• Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients.

  Psychopharmacology bulletin 20070101

• Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

  The Journal of clinical psychiatry 20070101

• Aripiprazole-associated acute dystonia.

  The Journal of neuropsychiatry and clinical neurosciences 20070101

• A case of aripiprazole-induced mania.

  Pharmacopsychiatry 20070101

• Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.

  Pharmacopsychiatry 20070101

• Does aripiprazole have a role in treating cognitive impairment in Parkinson's disease?

  The Journal of neuropsychiatry and clinical neurosciences 20070101

• 5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes.

  Clinical and experimental pharmacology & physiology 20070101

• Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101

• Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101

• Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.

  Clinical pharmacokinetics 20070101

• Mania in a case of hyperparathyroidism.

  Psychosomatics 20070101

• A case of ciprofloxacin-induced acute polymorphic psychosis with a distinct deficit in executive functions.

  Psychosomatics 20070101

• Cocaine use as a risk factor for ziprasidone-induced acute dystonia.

  General hospital psychiatry 20070101

• Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.

  Psychopharmacology bulletin 20070101

• Newer antipsychotics and the rabbit syndrome.

  Clinical practice and epidemiology in mental health : CP & EMH 20070101

• Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma.

  Psychosomatics 20070101

• Aripiprazole as the causative agent of neuroleptic malignant syndrome: a case report.

  Primary care companion to the Journal of clinical psychiatry 20070101

• Possible new causes for false-positive diagnosis of pheochromocytoma: lamotrigine, aripiprazole, or the combination.

  Primary care companion to the Journal of clinical psychiatry 20070101

• A case of acute dystonia after single dose of aripiprazole in a man with cocaine dependence.

  The American journal on addictions 20070101

• Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• Efficacy and safety of aripiprazole in alcohol dependence.

  The American journal of drug and alcohol abuse 20070101

• Epidemiology, diagnosis and management of mixed mania.

  CNS drugs 20070101

• Aripiprazole in a patient susceptible to urinary side effects of antipsychotics.

  The Israel journal of psychiatry and related sciences 20070101

• [Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics].

  L'Encephale 20070101

• [Clinical impact of aripiprazole in patients suffering from schizophrenia].

  L'Encephale 20070101

• Adjunctive treatment of acute mania: a clinical overview.

  Acta psychiatrica Scandinavica. Supplementum 20070101

• Bipolar II disorder : epidemiology, diagnosis and management.

  CNS drugs 20070101

• Atypical antipsychotics in children with pervasive developmental disorders.

  Paediatric drugs 20070101

• Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.

  BMC psychiatry 20070101

• The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• The prevalence and significance of substance use disorders in bipolar type I and II disorder.

  Substance abuse treatment, prevention, and policy 20070101

• Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report.

  Annals of general psychiatry 20070101

• Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.

  Annals of general psychiatry 20070101

• [Dopamine agonists--clinical applications beyond Parkinson's disease].

  Neurologia i neurochirurgia polska 20070101

• Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches.

  The American journal of drug and alcohol abuse 20070101

• The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.

  The American journal of drug and alcohol abuse 20070101

• Aripiprazole: in adolescents with schizophrenia.

  Paediatric drugs 20070101

• Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.

  The Journal of neuropsychiatry and clinical neurosciences 20070101

• Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients.

  Patient preference and adherence 20070101

• Clozapine: Current perspective.

  Indian journal of psychiatry 20070101

• Mania as an unique life event.

  Indian journal of psychiatry 20070101

• Paliperidone: the evidence of its therapeutic value in schizophrenia.

  Core evidence 20070101

• Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.

  European journal of pharmacology 20061215

• Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects.

  Brain research 20061208

• Aripiprazole is effective in the treatment of Tourette's disorder.

  The international journal of neuropsychopharmacology 20061201

• A model of anticholinergic activity of atypical antipsychotic medications.

  Schizophrenia research 20061201

• Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review.

  Schizophrenia research 20061201

• Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.

  Synapse (New York, N.Y.) 20061201

• Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study.

  Human psychopharmacology 20061201

• Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.

  Movement disorders : official journal of the Movement Disorder Society 20061201

• Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.

  Psychopharmacology 20061201

• Acute treatment of mania: an update on new medications.

  Current psychiatry reports 20061201

• Urinary obstruction with citalopram and aripiprazole combination in an elderly patient.

  Journal of clinical psychopharmacology 20061201

• Clozapine augmented with aripiprazole in 5 patients with schizophrenia.

  Journal of clinical psychopharmacology 20061201

• Efficacy with high-dose aripiprazole after olanzapine-related metabolic disturbances.

  The Annals of pharmacotherapy 20061201

• Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.

  Therapeutic drug monitoring 20061201

• Treatment of psychosis: 30 years of progress.

  Journal of clinical pharmacy and therapeutics 20061201

• Role of aripiprazole in treating mood disorders.

  Expert review of neurotherapeutics 20061201

• Relapse rates in patients with schizophrenia receiving aripiprazole in comparison with other atypical antipsychotics.

  The Journal of clinical psychiatry 20061201

• Long-term management strategies to achieve optimal function in patients with bipolar disorder.

  The Journal of clinical psychiatry 20061201

• Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice.

  Current medical research and opinion 20061201

• Treatments for late-life bipolar disorder.

  The American journal of geriatric pharmacotherapy 20061201

• [The use of atypical antipsychotics in the long-term care of schizophrenia].

  L'Encephale 20061201

• A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.

  Neuropsychiatric disease and treatment 20061201

• Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia.

  Neuropsychiatric disease and treatment 20061201

• Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.

  Journal of psychopharmacology (Oxford, England) 20061101

• Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.

  Current medical research and opinion 20061101

• Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia.

  The British journal of psychiatry : the journal of mental science 20061101

• [The antipsychotic drug aripiprazole (ABILIFY)].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20061101

• Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.

  Experimental and clinical psychopharmacology 20061101

• Diagnostic and therapeutic challenges in narcolepsy-related psychosis.

  The Journal of clinical psychiatry 20061101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20061101

• Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061020

• Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor.

  British journal of pharmacology 20061001

• Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.

  Psychopharmacology 20061001

• Aripiprazole in chronic schizophrenia: experiences in daily practice.

  Acta psychiatrica Scandinavica 20061001

• Sex selection bias in schizophrenia antipsychotic trials.

  Journal of clinical psychopharmacology 20061001

• Atypical neuroleptic malignant syndrome associated with aripiprazole.

  Journal of clinical psychopharmacology 20061001

• Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazole.

  Diabetes care 20061001

• Hyperlipidemia following treatment with antipsychotic medications.

  The American journal of psychiatry 20061001

• A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole.

  Human psychopharmacology 20061001

• Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.

  Journal of child and adolescent psychopharmacology 20061001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20061001

• Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.

  European journal of pharmacology 20060928

• A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.

  Drug and alcohol dependence 20060915

• Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901

• Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901

• Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901

• Aripiprazole associated with severe exacerbation of Parkinson's disease.

  Movement disorders : official journal of the Movement Disorder Society 20060901

• Aripiprazole exposures reported to Texas poison control centers during 2002-2004.

  Journal of toxicology and environmental health. Part A 20060901

• Meeting everyday challenges: antipsychotic therapy in the real world.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060901

• Differential metabolic effects of antipsychotic treatments.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060901

• The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia.

  CNS spectrums 20060901

• In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.

  Naunyn-Schmiedeberg's archives of pharmacology 20060901

• Maintenance treatment of bipolar disorder: Applying research to clinical practice.

  Journal of psychiatric practice 20060901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060901

• Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

  The Journal of clinical psychiatry 20060901

• Recurrent priapism associated with use of aripiprazole.

  The Journal of clinical psychiatry 20060901

• Switching in the era of atypical antipsychotics. An updated review.

  Postgraduate medicine 20060901

• Benefits of combining aripiprazole to clozapine: three case reports.

  Progress in neuro-psychopharmacology & biological psychiatry 20060830

• The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine.

  Psychopharmacology 20060801

• Neuroleptic malignant syndrome with aripiprazole and lithium: a case report.

  Journal of clinical psychopharmacology 20060801

• A case of dose-dependent aripiprazole-induced conduction disturbance.

  Journal of clinical psychopharmacology 20060801

• Long-term use of atypical antipsychotics in bipolar disorder.

  Pharmacotherapy 20060801

• Aripiprazole for schizophrenia. Systematic review.

  The British journal of psychiatry : the journal of mental science 20060801

• Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.

  CNS & neurological disorders drug targets 20060801

• Advanced pediatric psychopharmacology.

  Journal of child and adolescent psychopharmacology 20060801

• A pilot study of aripiprazole in children and adolescents with Tourette's disorder.

  Journal of child and adolescent psychopharmacology 20060801

• Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?

  Pharmacology, biochemistry, and behavior 20060801

• Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.

  The Journal of clinical psychiatry 20060801

• Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.

  The Journal of clinical psychiatry 20060801

• Haloperidol alone or in combination for acute mania.

  The Cochrane database of systematic reviews 20060719

• Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.

  Brain research 20060712

• A case of Aripiprazole and extra pyramidal side effects.

  Journal of psychopharmacology (Oxford, England) 20060701

• Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.

  Journal of psychopharmacology (Oxford, England) 20060701

• Aripiprazole and the neuroleptic malignant syndrome.

  Schizophrenia research 20060701

• Questionable advertising of psychotropic medications and disease mongering.

  PLoS medicine 20060701

• Tolerability of high-dose aripiprazole in treatment-refractory schizophrenic patients.

  The Journal of clinical psychiatry 20060701

• The metabolic effects of antipsychotic medications.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20060701

• Dementia with lewy bodies: therapeutic opportunities and pitfalls.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060701

• Use of aripiprazole for psychosis and agitation in dementia.

  International psychogeriatrics 20060601

• Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.

  Progress in neuro-psychopharmacology & biological psychiatry 20060601

• Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers.

  Bipolar disorders 20060601

• Aripiprazole use in a pregnant schizoaffective woman.

  Bipolar disorders 20060601

• Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.

  Pharmacotherapy 20060601

• Neuroleptic malignant syndrome and aripiprazole.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060601

• Aripiprazole-induced acute dystonia.

  The American journal of psychiatry 20060601

• Aripiprazole-related tardive dyskinesia.

  CNS spectrums 20060601

• Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses.

  The Journal of clinical psychiatry 20060601

• Aripiprazole-associated seizure.

  The Journal of clinical psychiatry 20060601

• [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].

  No to shinkei = Brain and nerve 20060601

• [Endocrine side effects among psychiatric patients treated with antipsychotics].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20060601

• Treatment of Alzheimer's disease across the spectrum of severity.

  Clinical interventions in aging 20060601

• Risperidone in the treatment of bipolar mania.

  Neuropsychiatric disease and treatment 20060601

• The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.

  Neuropsychiatric disease and treatment 20060601

• Bipolar disorders: treatment options and patient satisfaction.

  Neuropsychiatric disease and treatment 20060601

• Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting.

  Neuropsychiatric disease and treatment 20060601

• Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder.

  Neuropsychiatric disease and treatment 20060601

• Elevated lipase and diabetic ketoacidosis associated with aripiprazole.

  JOP : Journal of the pancreas 20060509

• A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).

  Schizophrenia research 20060501

• Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans.

  International clinical psychopharmacology 20060501

• Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?

  Movement disorders : official journal of the Movement Disorder Society 20060501

• Three cases of risperidone-induced enuresis.

  Schizophrenia research 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Aripiprazole reduces acute mania compared with haloperidol in bipolar I disorder and causes fewer adverse effects.

  Evidence-based mental health 20060501

• Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.

  The American journal of psychiatry 20060501

• Psychiatric decision making in the adoption of a new antipsychotic in Germany.

  Psychiatric services (Washington, D.C.) 20060501

• Aripiprazole pharmacotherapy of borderline personality disorder.

  Pharmacopsychiatry 20060501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060501

• Aripiprazole for schizophrenia.

  The Cochrane database of systematic reviews 20060419

• Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis.

  Journal of neurology 20060401

• Acute dystonia with low-dosage aripiprazole in Tourette's disorder.

  The Annals of pharmacotherapy 20060401

• Naturalistic impact of second-generation antipsychotics on weight gain.

  The Annals of pharmacotherapy 20060401

• Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.

  The Journal of clinical psychiatry 20060401

• A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

  The Journal of clinical psychiatry 20060401

• High-dose aripiprazole in treatment-resistant schizophrenia.

  The Journal of clinical psychiatry 20060401

• Clozapine augmentation with aripiprazole for negative symptoms.

  The Journal of clinical psychiatry 20060401

• Aripiprazole in childhood and adolescence for Tourette syndrome.

  Journal of child neurology 20060401

• Acute akathisia with suicidal ideation associated with low dose aripiprazole.

  Psychiatry (Edgmont (Pa. : Township)) 20060401

• Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.

  European journal of pharmacology 20060327

• Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.

  European journal of pharmacology 20060318

• Extrapyramidal side effects with atypical neuroleptics in bipolar disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20060301

• Aripiprazole and suicidality.

  International clinical psychopharmacology 20060301

• Aripiprazole-induced parkinsonism.

  International clinical psychopharmacology 20060301

• Treatment-resistant bipolar disorder.

  Molecular psychiatry 20060301

• Use of aripiprazole during late pregnancy in a woman with psychotic illness.

  The Annals of pharmacotherapy 20060301

• [No rebound psychosis in a case of switching from clozapine to quetiapine].

  Psychiatrische Praxis 20060301

• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060301

• Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report.

  Pharmacopsychiatry 20060301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060301

• Substance abuse in patients with schizophrenia.

  Dialogues in clinical neuroscience 20060301

• A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.

  Dialogues in clinical neuroscience 20060301

• [Clinical observations with aripiprazole in schizophrenia].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20060301

• Marked improvement in chronic tardive dyskinesia after changing to aripiprazole.

  Psychiatry (Edgmont (Pa. : Township)) 20060301

• [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].

  Nederlands tijdschrift voor geneeskunde 20060218

• [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].

  Nederlands tijdschrift voor geneeskunde 20060218

• Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms.

  Biochemical pharmacology 20060214

• Emerging treatments for bipolar disorder: safety and adverse effect profiles.

  The Annals of pharmacotherapy 20060201

• Neuroleptic malignant syndrome and aripiprazole in an antipsychotic-naive patient.

  Journal of clinical psychopharmacology 20060201

• Aripiprazole as a dopamine partial agonist: positive and negative effects.

  Journal of clinical psychopharmacology 20060201

• An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.

  Acta psychiatrica Scandinavica 20060201

• Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study.

  Acta psychiatrica Scandinavica 20060201

• Aripiprazole-induced extrapyramidal side effects in a patient with schizoaffective disorder.

  The Australian and New Zealand journal of psychiatry 20060201

• Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.

  Pharmacopsychiatry 20060201

• The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

  The Cochrane database of systematic reviews 20060125

• TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism.

  Medical hypotheses 20060101

• Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.

  The pharmacogenomics journal 20060101

• Oxcarbazepine-induced thrombocytopenia.

  Psychosomatics 20060101

• Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

  Psychosomatics 20060101

• Aripiprazole-induced movement disorder.

  The American journal of psychiatry 20060101

• Interactions between antiepileptic and antipsychotic drugs.

  Drug safety 20060101

• Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre.

  BMC psychiatry 20060101

• Update on the biological treatment of aggression.

  Actas espanolas de psiquiatria 20060101

• Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.

  Drug safety 20060101

• [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

  L'Encephale 20060101

• Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.

  American journal of Alzheimer's disease and other dementias 20060101

• Review of evidence that posttransplantation psychiatric treatment commonly affects prolactin levels and thereby influences graft fate.

  General hospital psychiatry 20060101

• Aripiprazole in patients with Tourette syndrome.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20060101

• Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20060101

• Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

  CNS drugs 20060101

• Pharmacological treatment of ambulatory schizophrenic patients in Belgium.

  Clinical practice and epidemiology in mental health : CP & EMH 20060101

• Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101

• The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

  Molecular diagnosis & therapy 20060101

• [Pharmacology of antipsychotic drugs]].

  L'Encephale 20060101

• Economics of atypical antipsychotics in bipolar disorder: a review of the literature.

  CNS drugs 20060101

• Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

  Drug safety 20060101

• Aripiprazole-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH).

  American journal of therapeutics 20060101

• An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression.

  Primary care companion to the Journal of clinical psychiatry 20060101

• Aripiprazole therapy for nicotine dependence.

  Primary care companion to the Journal of clinical psychiatry 20060101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060101

• Adjunctive aripiprazole in treatment-resistant bipolar depression.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101

• Aripiprazole in the treatment of delirium.

  Psychosomatics 20060101

• Tardive dystonia-associated prescription of aripiprazole.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Neuroacanthocytosis: presenting with depression.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Long-term management strategies to achieve optimal function in patients with bipolar disorder.

  The Journal of clinical psychiatry 20060101

• Children with schizophrenia: clinical picture and pharmacological treatment.

  CNS drugs 20060101

• A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole.

  The Journal of the Oklahoma State Medical Association 20060101

• Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.

  Psychopharmacology bulletin 20060101

• Adverse effects of atypical antipsychotics in the elderly: a review.

  Drugs & aging 20060101

• Aripiprazole and delirium.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101

• Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.

  Clinical drug investigation 20060101

• Synthesis and bioactivity of aripiprazole derivatives.

  Arzneimittel-Forschung 20060101

• Aripiprazole worsens psychosis: a case report.

  Primary care companion to the Journal of clinical psychiatry 20060101

• Aripiprazole: the evidence of its therapeutic impact in schizophrenia.

  Core evidence 20060101

• Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.

  Neuropharmacology 20051201

• Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.

  The Journal of pharmacology and experimental therapeutics 20051201

• Priapism associated with oxcarbazepine, aripiprazole, and lithium.

  Journal of the American Academy of Child and Adolescent Psychiatry 20051201

• Hypertension and aripiprazole.

  The American journal of psychiatry 20051201

• Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.

  Archives of general psychiatry 20051201

• Overdoses and ingestions of second-generation antipsychotics in children and adolescents.

  Journal of child and adolescent psychopharmacology 20051201

• The patient with schizophrenia taking aripiprazole: case report.

  Psychiatria Danubina 20051201

• Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.

  Neuropsychiatric disease and treatment 20051201

• Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051101

• Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.

  The Annals of pharmacotherapy 20051101

• Treatment of withdrawal dyskinesia.

  Journal of the American Academy of Child and Adolescent Psychiatry 20051101

• Weight change with atypical antipsychotics in the treatment of schizophrenia.

  Journal of psychopharmacology (Oxford, England) 20051101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20051101

• Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.

  The journal of medical investigation : JMI 20051101

• Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies.

  The Journal of clinical psychiatry 20051101

• Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex.

  Neuroscience letters 20051028

• Synthesis of biologically active amines via rhodium-bisphosphite-catalyzed hydroaminomethylation.

  Organic letters 20051027

• Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

  JAMA 20051019

• Second generation antipsychotics--aripiprazole revisited.

  The Medical letter on drugs and therapeutics 20051010

• [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].

  Nederlands tijdschrift voor geneeskunde 20051008

• Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.

  The Journal of pharmacology and experimental therapeutics 20051001

• Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.

  Psychopharmacology 20051001

• Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study.

  Journal of clinical psychopharmacology 20051001

• Catatonia and psychosis in a patient with AIDS: treatment with lorazepam and aripiprazole.

  Journal of clinical psychopharmacology 20051001

• Diabetic ketoacidosis associated with aripiprazole.

  Diabetic medicine : a journal of the British Diabetic Association 20051001

• Aripiprazole.

  Expert opinion on pharmacotherapy 20051001

• Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.

  The Journal of clinical psychiatry 20051001

• Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.

  The Journal of clinical psychiatry 20051001

• Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania?

  The Journal of clinical psychiatry 20051001

• Treatment-emergent psychosis with aripiprazole.

  The Journal of clinical psychiatry 20051001

• Aripiprazole: new drug. Just another neuroleptic.

  Prescrire international 20051001

• Atypical antipsychotics: special formulations for acute agitation.

  Journal of psychosocial nursing and mental health services 20051001

• Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20051001

• Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder.

  Psychiatry research 20050915

• Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia.

  The international journal of neuropsychopharmacology 20050901

• Case series on the use of aripiprazole for Tourette syndrome.

  The international journal of neuropsychopharmacology 20050901

• Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats.

  Psychopharmacology 20050901

• Clozapine-induced hyperlipidemia resolved after switch to aripiprazole therapy.

  The Annals of pharmacotherapy 20050901

• Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection.

  Clinical chemistry 20050901

• Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.

  The British journal of psychiatry : the journal of mental science 20050901

• Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.

  The Australian and New Zealand journal of psychiatry 20050901

• Atypical antipsychotics and the burden of disease.

  The American journal of managed care 20050901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050901

• [Determination of aripiprazole by nonaqueous reversed-phase high performance liquid chromatography].

  Se pu = Chinese journal of chromatography 20050901

• Atypical antipsychotics in the management of delirium: a review of the empirical literature.

  Palliative & supportive care 20050901

• Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.

  Neuropsychiatric disease and treatment 20050901

• Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805

• Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.

  Neuropharmacology 20050801

• Aripiprazole in schizophrenia with cocaine dependence: a pilot study.

  Journal of clinical psychopharmacology 20050801

• Safety and tolerability of emerging pharmacological treatments for bipolar disorder.

  Bipolar disorders 20050801

• Reversal of symptomatic hyperprolactinemia by aripiprazole.

  The American journal of psychiatry 20050801

• The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation.

  Psychiatry (Edgmont (Pa. : Township)) 20050801

• ['Awakening': a confusing improvement during treatment with atypical antipsychotic agents].

  Nederlands tijdschrift voor geneeskunde 20050730

• The crossover approach to switching antipsychotics: what is the evidence?

  Schizophrenia research 20050715

• High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050705

• Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics.

  International clinical psychopharmacology 20050701

• The place of partial agonism in psychiatry: recent developments.

  Journal of psychopharmacology (Oxford, England) 20050701

• Higher than Physician's Desk Reference (US) doses on atypical antipsychotics.

  Expert opinion on drug safety 20050701

• One-year experience with aripiprazole exposures.

  The American journal of emergency medicine 20050701

• Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.

  Journal of psychiatric practice 20050701

• Aripiprazole in children and adolescents: clinical experience.

  Journal of child neurology 20050701

• Modern antipsychotic drugs: a critical overview.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20050621

• [Aripiprazole in the treatment of schizophrenia].

  Praxis 20050608

• Atypical antipsychotics for bipolar disorder.

  The Psychiatric clinics of North America 20050601

• High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity.

  Progress in neuro-psychopharmacology & biological psychiatry 20050601

• Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.

  The Journal of clinical psychiatry 20050601

• An African patient with ziprasidone intolerance.

  The Journal of clinical psychiatry 20050601

• Fatal stroke with aripiprazole.

  Prescrire international 20050601

• Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?

  European archives of psychiatry and clinical neuroscience 20050601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050601

• Aripiprazole: an overview of a novel antipsychotic.

  Psychiatria Danubina 20050601

• Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders.

  Neuropsychiatric disease and treatment 20050601

• Atypical presentations of atypical antipsychotics.

  Psychiatry (Edgmont (Pa. : Township)) 20050601

• FDA warns antipsychotic drugs may be risky for elderly.

  JAMA 20050525

• Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.

  European journal of pharmacology 20050516

• Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.

  Brain research 20050510

• Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.

  Journal of affective disorders 20050501

• [Haematological abnormalities during treatment with atypical antipsychotics].

  Psychiatrische Praxis 20050501

• [Rabbit syndrome due to olanzapine].

  Psychiatrische Praxis 20050501

• Partial dopamine agonists in schizophrenia.

  Hospital medicine (London, England : 1998) 20050501

• Aripiprazole: pharmacology, efficacy, safety and tolerability.

  Expert review of neurotherapeutics 20050501

• Overdose of aripiprazole, a new type of antipsychotic.

  The Journal of emergency medicine 20050401

• Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?

  Current opinion in pediatrics 20050401

• Partial agonists in schizophrenia.

  The British journal of psychiatry : the journal of mental science 20050401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050401

• Aripiprazole in schizophrenia: consensus guidelines.

  International journal of clinical practice 20050401

• Aripiprazole: novelty, adherence and understatement.

  The international journal of neuropsychopharmacology 20050301

• Aripiprazole in a patient vulnerable to side effects.

  The American journal of psychiatry 20050301

• Aripiprazole and depression in schizoaffective disorder.

  The American journal of psychiatry 20050301

• Increased efficacy with addition of clozapine to aripiprazole: alternative explanations.

  The Journal of clinical psychiatry 20050301

• The treatment of mixed states and the risk of switching to depression.

  European psychiatry : the journal of the Association of European Psychiatrists 20050301

• Aripiprazole-induced seizure.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• Improvement in tardive dyskinesia with aripiprazole use.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• Galactorrhea with aripiprazole.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• Aripiprazole reduces alcohol use.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• Normalization of risperidone-induced hyperprolactinemia with the addition of aripiprazole.

  Psychiatry (Edgmont (Pa. : Township)) 20050301

• Treatment of tics in tourette syndrome with aripiprazole.

  Journal of clinical psychopharmacology 20050201

• Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.

  The American journal of psychiatry 20050201

• Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review.

  CNS spectrums 20050201

• Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.

  Expert opinion on pharmacotherapy 20050201

• Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE.

  Drug metabolism and pharmacokinetics 20050201

• Aripiprazole augmentation of clozapine: in refractory schizophrenia.

  Psychiatry (Edgmont (Pa. : Township)) 20050201

• [Psychiatry].

  Revue medicale suisse 20050112

• Treatment of acute mania--from clinical trials to recommendations for clinical practice.

  Human psychopharmacology 20050101

• Aripiprazole-associated dyskinesia.

  The Annals of pharmacotherapy 20050101

• Pharmacokinetics of aripiprazole and concomitant lithium and valproate.

  Journal of clinical pharmacology 20050101

• Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.

  International clinical psychopharmacology 20050101

• Partial agonism and schizophrenia.

  The British journal of psychiatry : the journal of mental science 20050101

• Managing bipolar disorder in the elderly: defining the role of the newer agents.

  Drugs & aging 20050101

• The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.

  The Journal of clinical psychiatry 20050101

• Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.

  The Journal of clinical psychiatry 20050101

• Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole.

  Drugs of today (Barcelona, Spain : 1998) 20050101

• The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.

  The Journal of clinical psychiatry 20050101

• Aripiprazole and bone pain.

  Psychosomatics 20050101

• Is leukopenia associated with divalproex and/or quetiapine?

  Psychosomatics 20050101

• The art of prescribing. Principles of switching novel antipsychotic medications.

  Perspectives in psychiatric care 20050101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050101

• Atypical antipsychotic therapy and hyperlipidemia: a review.

  Essential psychopharmacology 20050101

• The dosing of atypical antipsychotics.

  Psychosomatics 20050101

• Atypical experience: a case series of pediatric aripiprazole exposures.

  Clinical toxicology (Philadelphia, Pa.) 20050101

• Aripiprazole (abilify) overdose in a child.

  Clinical toxicology (Philadelphia, Pa.) 20050101

• [Combining effectiveness and tolerance].

  Krankenpflege Journal 20050101

• Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation.

  Medical hypotheses 20050101

• Atypical antipsychotics: newer options for mania and maintenance therapy.

  Bipolar disorders 20050101

• The novel atypical antipsychotic aripiprazole as treatment for and prophylaxis against progressive multifocal leukoencephalopathy.

  Medical hypotheses 20050101

• Aripiprazole prescribing and continuation rates during psychiatric hospitalization.

  The Annals of pharmacotherapy 20050101

• Spotlight on olanzapine in bipolar I disorder.

  CNS drugs 20050101

• Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome.

  International journal of adolescent medicine and health 20050101

• Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

  CNS drugs 20050101

• [Drug-induced diabetes mellitus: the exemple of atypical antipsychotics].

  Revue medicale de Liege 20050101

• A typical mood stabilizers: a 'typical role for atypical antipsychotics.

  Acta psychiatrica Scandinavica. Supplementum 20050101

• Aripiprazole treatment for psychosis associated with Friedreich's ataxia.

  General hospital psychiatry 20050101

• Aripiprazole in psychosis associated with Parkinson's disease.

  The Journal of neuropsychiatry and clinical neurosciences 20050101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050101

• Management options for bipolar disorder in children and adolescents.

  Paediatric drugs 20050101

• Antipsychotic poisoning in young children: a systematic review.

  Drug safety 20050101

• Galactorrhea with aripiprazole.

  Psychotherapy and psychosomatics 20050101

• Use of atypical antipsychotics in refractory depression and anxiety.

  The Journal of clinical psychiatry 20050101

• Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication.

  The Journal of neuropsychiatry and clinical neurosciences 20050101

• Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.

  PharmacoEconomics 20050101

• Atypicality of atypical antipsychotics.

  Primary care companion to the Journal of clinical psychiatry 20050101

• Aripiprazole for the treatment of Tourette's disorder.

  Primary care companion to the Journal of clinical psychiatry 20050101

• Aripiprazole in the treatment of delirium.

  International journal of psychiatry in medicine 20050101

• Psychotropic drug utilization pattern among patients with schizophrenia.

  Indian journal of psychiatry 20050101

• Aripiprazole augmentation of combination escitalopram and sertraline in the treatment of refractory obsessive-compulsive disorder.

  Psychiatry (Edgmont (Pa. : Township)) 20050101

• Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain.

  Molecular pharmacology 20041201

• Pharmacology of antipsychotics in the elderly: a focus on atypicals.

  Journal of the American Geriatrics Society 20041201

• Optimizing atypical antipsychotic treatment strategies in the elderly.

  Journal of the American Geriatrics Society 20041201

• A taxpayer-funded clinical trials registry and results database.

  PLoS medicine 20041201

• Aripiprazole and atypical neuroleptic malignant syndrome.

  Journal of the American Academy of Child and Adolescent Psychiatry 20041201

• Severe extrapyramidal symptoms in a 3-year-old boy after accidental ingestion of the new antipsychotic drug aripiprazole.

  Pediatrics 20041201

• Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.

  Progress in neuro-psychopharmacology & biological psychiatry 20041201

• Aripiprazole as an adjunctive treatment for refractory major depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20041201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041201

• Metabolic risk during antipsychotic treatment.

  Clinical therapeutics 20041201

• [A new atypical antipsychotic with partial dopamine agonist effect (aripiprazole)].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201

• Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041115

• Aripiprazole and neuroleptic malignant syndrome.

  International clinical psychopharmacology 20041101

• Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies.

  CNS spectrums 20041101

• Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101

• Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.

  The Journal of clinical psychiatry 20041101

• [Aripiprazol. An atypical neuroleptic with exceptional mechanisms of action] ].

  Medizinische Monatsschrift fur Pharmazeuten 20041101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041101

• Treatment of bipolar mania with atypical antipsychotics.

  Expert review of neurotherapeutics 20041101

• Maintenance therapy for bipolar disorder: current and future management options.

  Expert review of neurotherapeutics 20041101

• Chronic interictal psychosis responsive to aripiprazole.

  Journal of clinical psychopharmacology 20041001

• Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.

  Journal of clinical psychopharmacology 20041001

• The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research.

  Bipolar disorders 20041001

• Aripiprazole for acute bipolar mania.

  The American journal of psychiatry 20041001

• Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.

  CNS spectrums 20041001

• The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.

  Postgraduate medicine 20041001

• [Anticonvulsants and antipsychotics in the treatment of bipolar disorder].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20041001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041001

• The effects of antipsychotic therapy on serum lipids: a comprehensive review.

  Schizophrenia research 20040901

• Aripiprazole and psychotherapy for delusional disorder, erotomanic type.

  Journal of the American Academy of Child and Adolescent Psychiatry 20040901

• Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.

  Journal of psychopharmacology (Oxford, England) 20040901

• Dosage and administration issues of antipsychotic agents (and adjunctive medicines) in the acute stabilization of psychoses.

  CNS spectrums 20040901

• [Aripiprazole: a new atypical antipsychotic drug].

  Fortschritte der Neurologie-Psychiatrie 20040901

• Possible increased efficacy of low-dose clozapine when combined with aripiprazole.

  The Journal of clinical psychiatry 20040901

• Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.

  The Journal of clinical psychiatry 20040901

• [Expectation and development of atypical antipsychotic drugs].

  Therapeutische Umschau. Revue therapeutique 20040901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040901

• [Aripiprazole and Tourette syndrome].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20040901

• [Expectations and developments in atypical antipsychotics].

  Praxis 20040825

• [Psychotropics and weight gain].

  Praxis 20040825

• The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome.

  Sleep 20040801

• Worsening schizoaffective disorder with aripiprazole.

  The American journal of psychiatry 20040701

• Aripiprazole-induced rabbit syndrome.

  The Australian and New Zealand journal of psychiatry 20040701

• Pharmacological treatment strategies for schizophrenia.

  Expert review of neurotherapeutics 20040701

• Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.

  European journal of pharmacology 20040616

• Evidence-based pharmacotherapy of schizophrenia.

  The international journal of neuropsychopharmacology 20040601

• Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia.

  Evidence-based mental health 20040501

• Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.

  Clinical therapeutics 20040501

• The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release.

  Brain research 20040402

• Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats.

  Psychopharmacology 20040401

• Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.

  Current drug targets 20040401

• Excessive somnolence from aripiprazole in a child.

  Pharmacotherapy 20040401

• The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.

  The Journal of clinical psychiatry 20040401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040401

• Dose response and dose equivalence of antipsychotics.

  Journal of clinical psychopharmacology 20040401

• Therapeutic monitoring of new antipsychotic drugs.

  Therapeutic drug monitoring 20040401

• International Congress of Biological Psychiatry. 8-13 February 2004, Sydney, Australia.

  IDrugs : the investigational drugs journal 20040301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040301

• Selection of atypical antipsychotics for the management of schizophrenia.

  The Annals of pharmacotherapy 20040201

• Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers.

  Journal of clinical pharmacology 20040201

• Aripiprazole and Parkinson's disease psychosis.

  The American journal of psychiatry 20040201

• Aripiprazole is effective against the symptoms of schizophrenia and schizoaffective disorder.

  Evidence-based mental health 20040201

• Schizophrenia: from dopamine to glutamate and back.

  Current medicinal chemistry 20040201

• Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.

  Current medicinal chemistry 20040201

• Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics.

  Current medicinal chemistry 20040201

• A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation.

  Current medicinal chemistry 20040201

• Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.

  Current medicinal chemistry 20040201

• Aripiprazole, a novel atypical antipsychotic drug.

  Pharmacotherapy 20040201

• Aripirazole-olanzapine combination for treatment of schizophrenia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040201

• In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.

  European journal of pharmacology 20040101

• Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

  Paediatric drugs 20040101

• Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?

  The Journal of clinical psychiatry 20040101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040101

• Using antipsychotic agents in older patients.

  The Journal of clinical psychiatry 20040101

• Focus on aripiprazole.

  Current medical research and opinion 20040101

• Dopamine partial agonists: a new class of antipsychotic.

  CNS drugs 20040101

• Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

  Drugs 20040101

• Aripiprazole: in acute mania associated with bipolar I disorder.

  CNS drugs 20040101

• Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience.

  Clinical neuropharmacology 20040101

• Aripiprazole possibly worsens psychosis.

  International clinical psychopharmacology 20040101

• Aripiprazole for schizophrenia.

  The Cochrane database of systematic reviews 20040101

• Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.

  BMC psychiatry 20040101

• The case for atypical antipsychotics in bipolar disorder.

  Perspectives in psychiatric care 20040101

• Clinical utilization of atypical antipsychotics in pregnancy and lactation.

  The Annals of pharmacotherapy 20040101

• Dose response and atypical antipsychotics in schizophrenia.

  CNS drugs 20040101

• The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting.

  Journal of the American Medical Directors Association 20040101

• Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.

  Drugs 20040101

• Efficacy of atypical antipsychotics in elderly patients with dementia.

  The Journal of clinical psychiatry 20040101

• Drug development for anxiety disorders: new roles for atypical antipsychotics.

  Psychopharmacology bulletin 20040101

• Drug therapy in schizophrenia.

  Current pharmaceutical design 20040101

• Side effects of atypical antipsychotic drugs.

  Current pharmaceutical design 20040101

• Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

  Current pharmaceutical design 20040101

• Atypical antipsychotic induced weight gain: pathophysiology and management.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101

• Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

  Drugs 20040101

• Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.

  Medical hypotheses 20040101

• Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101

• Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

  CNS drugs 20040101

• Olanzapine: a review of its use in the management of bipolar I disorder.

  Drugs 20040101

• Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.

  CNS drug reviews 20040101

• A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.

  The Journal of clinical psychiatry 20040101

• Second-generation antipsychotic medications in children and adolescents.

  Journal of child and adolescent psychopharmacology 20040101

• Aripiprazole for maladaptive behavior in pervasive developmental disorders.

  Journal of child and adolescent psychopharmacology 20040101

• Aripiprazole in the treatment of bipolar disorder in children and adolescents.

  Journal of child and adolescent psychopharmacology 20040101

• The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.

  Journal of child and adolescent psychopharmacology 20040101

• Aripiprazole augmentation in treatment-resistant depression.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101

• Sexuality and schizophrenia: a review.

  Schizophrenia bulletin 20040101

• The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management.

  Metabolic syndrome and related disorders 20040101

• Open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of Indian patients of schizophrenia.

  Indian journal of psychiatry 20040101

• Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders.

  Indian journal of psychiatry 20040101

• Efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders.

  Indian journal of psychiatry 20040101

• Aripiprazole induced severe parkinsonian symptoms - a case report.

  Indian journal of psychiatry 20040101

• Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

  The international journal of neuropsychopharmacology 20031201

• Relationship of atypical antipsychotics with development of diabetes mellitus.

  The Annals of pharmacotherapy 20031201

• Aripiprazole.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031201

• Medication developments in the treatment of mental illness.

  Behavioral healthcare tomorrow 20031201

• Aripiprazole-induced improvement in tardive dyskinesia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20031201

• Aripiprazole in an adult with Asperger disorder.

  The Annals of pharmacotherapy 20031101

• Aripiprazole and extrapyramidal symptoms.

  Journal of the American Academy of Child and Adolescent Psychiatry 20031101

• European College of Neuropsychopharmacology - 16th Congress. 20-24 September 2003, Prague, Czech Republic.

  IDrugs : the investigational drugs journal 20031101

• Mechanism of new antipsychotic medications: occupancy is not just antagonism.

  Archives of general psychiatry 20031001

• Serotonin receptors: their key role in drugs to treat schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20031001

• A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.

  The American journal of psychiatry 20030901

• Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.

  The Journal of clinical psychiatry 20030901

• Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030801

• Treatment for mood and anxiety disorders: quetiapine and aripiprazole.

  Current psychiatry reports 20030801

• [The next generation of 'atypical' antipsychotics: the role of positron emission tomography].

  Fortschritte der Neurologie-Psychiatrie 20030801

• Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.

  European journal of pharmacology 20030704

• Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.

  European journal of pharmacology 20030704

• Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).

  Journal of medicinal chemistry 20030703

• Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.

  Archives of general psychiatry 20030701

• Antipsychotic medication and seizures: a review.

  Drugs of today (Barcelona, Spain : 1998) 20030701

• Relating clinical trials to psychiatric practice: part I: the case of a 13-year old on aripiprazole and fluoxetine.

  Journal of psychiatric practice 20030701

• Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.

  Schizophrenia research 20030601

• Aripiprazole.

  Nature reviews. Drug discovery 20030601

• Chlorpromazine equivalent doses for the newer atypical antipsychotics.

  The Journal of clinical psychiatry 20030601

• Aripiprazole.

  The Harvard mental health letter 20030601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030601

• Advances in pharmacotherapy of psychotic disorders in the elderly.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20030601

• Aripiprazole: a new atypical antipsychotic drug.

  The Annals of pharmacotherapy 20030501

• Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?

  The Annals of pharmacotherapy 20030501

• Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.

  Psychopharmacology 20030401

• Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.

  Expert opinion on investigational drugs 20030401

• Aripiprazole: quite possibly a new type of antipsychotic.

  South Dakota journal of medicine 20030401

• H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030301

• alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.

  European journal of pharmacology 20030221

• Aripiprazole (Abilify) for schizophrenia.

  The Medical letter on drugs and therapeutics 20030217

• Aripiprazole. The newest antipsychotic agent for treatment of schizophrenia.

  Journal of psychosocial nursing and mental health services 20030201

• Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic.

  Drugs of today (Barcelona, Spain : 1998) 20030201

• Synthetic study on the unique dimeric arylpiperazine: access to the minor contaminant of aripiprazole.

  Bioorganic & medicinal chemistry letters 20030106

• Aripiprazole: a review of its pharmacology and clinical use.

  International journal of clinical practice 20030101

• New product intros.

  Drug news & perspectives 20030101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030101

• New developments in the pharmacotherapy of schizophrenia.

  Journal of neural transmission. Supplementum 20030101

• Choice of maintenance medication for schizophrenia.

  The Journal of clinical psychiatry 20030101

• Similarities and differences among antipsychotics.

  The Journal of clinical psychiatry 20030101

• The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.

  The Journal of clinical psychiatry 20030101

• Aripiprazole: profile on efficacy and safety.

  Expert opinion on pharmacotherapy 20021201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021201

• Optimizing dosing in atypical neuroleptic monotherapy.

  Dialogues in clinical neuroscience 20021201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021101

• Antipsychotics: impact on prolactin levels.

  Expert opinion on pharmacotherapy 20021001

• Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

  The Journal of clinical psychiatry 20020901

• Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020801

• Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

  The Journal of pharmacology and experimental therapeutics 20020701

• Psychotropic drugs and the ECG: focus on the QTc interval.

  Expert opinion on pharmacotherapy 20020501

• The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.

  European journal of pharmacology 20020426

• Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis.

  Current drug targets. CNS and neurological disorders 20020401

• Partial dopamine agonists in the treatment of psychosis.

  Journal of neural transmission (Vienna, Austria : 1996) 20020301

• Aripiprazole. Abilitat, OPC 14597.

  Drugs in R&D 20020101

• Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.

  CNS drugs 20020101

• Aripiprazole (Otsuka Pharmaceutical Co).

  Current opinion in investigational drugs (London, England : 2000) 20020101

• Aripiprazole.

  CNS drugs 20020101

• Biological perspectives. Aripiprazole: a third generation of antipsychotics begins?

  Perspectives in psychiatric care 20020101

• Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.

  The Journal of clinical psychiatry 20011201

• Treatments for chronic psychosis.

  Dialogues in clinical neuroscience 20011201

• Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, 'Goldilocks' actions at dopamine receptors.

  The Journal of clinical psychiatry 20011101

• In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol.

  Toxicology and applied pharmacology 20010601

• Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.

  Molecular pharmacology 20000101

• Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19990601

• Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland.

  The Journal of pharmacology and experimental therapeutics 19960401